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 Abstract 
  
ABSTRACT 
 
The oxidative phosphorylation system comprises three fundamental processes: electron 
transport, proton pumping and ATP synthesis. Electron transport is required for both 
anabolic and catabolic processes, which require the delivery of electrons to the 
mitochondrial electron chain. This flux of electrons drives proton pumping and generates an 
electrochemical gradient across the mitochondrial inner membrane. This gradient is used 
by ATP synthase (ATPase, complex V) to generate ATP. Electron transport and proton 
pumping can be detached in many non-mammalian eukaryotes because they have non-
proton-pumping oxidases. Mitochondrial ATPase is structured in two domains, the FO 
domain, hydrophobic and embedded in the mitochondrial inner membrane, and the F1 
domain, hydrophilic, which protrudes through the mitochondrial matrix and is responsible 
for the ATP synthesis from ADP and Pi. In recent years, new ATPase subunits have been 
discovered: DAPIT and 6.8kDa protein (MP68). Very little is known about them, but DAPIT 
has been related with glucose metabolism and diabetes. They have been recently reported 
to form an ATPase subdomain called the intermembrane space domain (IMD), formed by 
only these two proteins. In this thesis, the functional role of DAPIT and MP68 was 
evaluated by generating knockout mouse models. An opposite role for each one was 
demonstrated: while DAPIT promotes ATPase dimerisation, MP68 prevents it. In the 
absence of DAPIT, an ATPase subcomplex is dissociated, which indicates that DAPIT 
promotes ATPase structure maintenance. 
 
Next we focused on developing cellular tools where mitochondrial ATP synthesis capacity 
could be studied separately from electron transport. For this purpose, we designed 
optogenetic tools to generate an electrochemical gradient in mitochondria. Optogenetic 
tools were initially used in the neural field to modify and control the channel flux in neurons 
to alter their activity. Here we transformed light energy into an energy, that cells can use to 
grow. By expressing deltarhodopsin in mammalian cells, we were able to rescue energy 
deficiencies using light as a source of energy.  
  Resumen 
 RESUMEN 
 
 
El sistema de fosforilación oxidativa concentra tres funciones principales: el transporte de 
electrones, el bombeo de protones y la síntesis de ATP. El transporte de electrones es 
requerido para procesos anabólicos y catabólicos en los que participan las reacciones de 
oxidación–reducción que se llevan a cabo en la mitocondria. El bombeo de protones está 
impulsado por el flujo de electrones, y genera un gradiente electroquímico en la membrana 
interna mitocondrial. Este gradiente es utilizado por la ATP sintasa (ATPasa o complejo V) 
para la síntesis de ATP. Los procesos de transporte de electrones y el bombeo de 
protones solo pueden desacoplarse en organismos eucariotas no mamíferos, ya que 
presentan oxidasas que no bombean protones. La ATPasa mitocondrial está formada por 
dos dominios, el dominio FO, hidrofóbico, embebido en la membrana interna; y el dominio 
F1, hidrofílico, localizado hacia la matriz mitocondrial, y que contiene la estructura 
responsable de la síntesis de ATP a partir de ADP y fosfato inorgánico. En los últimos 
años, se han descubierto nuevas subunidades, DAPIT y la proteína 6.8kDa (MP68). La 
función de mabas es poco conocida, pero DAPIT ha sido relacionada con el metabolismo 
de la glucosa y diabetes. Recientemente, se ha descrito un nuevo subdominio de la 
ATPasa llamado “dominio del espacio intermembrana” (IMD) que está formado únicamente 
por ambas proteínas. En esta tesis, se ha evaluado la función de DAPIT y MP68 
generando ratones con falta de función para cada una de ellas, demostrando su función 
opuesta entre ellas. Mientras que DAPIT promueve la formación de dímeros de ATPasa, 
MP68 promuve su disociación. Además, en ausencia de DAPIT se genera un subcomplejo 
de ATPasa, indicando que DAPIT promueve el mantenimiento de la estructura de este 
complejo.  
 
Por otro lado, en esta tesis se han desarrollado herramientas celulares para estudiar la 
capacidad de síntesis de ATP de forma independiente al transporte de electrones. Para 
ello, se han utilizado herramientas optogenéticas. Estas técnicas se han utilizado 
tradicionalmente en estudios neurales, para modificar y controlar el flujo a través de 
canales modificando su actividad. En esta tesis, se han desarrollado células capaces de 
transformar la energía de la luz en energía aprovechable para crecer. Gracias a la 
expresión de una deltarodopsina en células de mamífero, éstas son capaces de rescatar 
deficiencias energéticas usando la luz como fuente de energía.  
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 Å    Ångström  
A/BA    Acrylamide/bis-acrylamide 
ADP    Adenosine diphosphate 
ATP    Adenosine triphosphate 
ATPase   ATP synthase  
BN    Blue native 
bp    (DNA) base pairs     
BSA    Bovine serum albumin 
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rev/s    Revolutions per second  
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SDS    Sodium dodecyl sulphate 
STZ    Streptozotocin 
TCA    Tricarboxylic acid cycle 
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I. MITOCHONDRIA BIOLOGY 
 
 
I.1 Mitochondrial function 
 
 
Mitochondria are endosymbiotic organelles that harbour different critical functions, provide 
energy to cells in the form of ATP, and also harbour the TCA cycle and beta oxidation of 
fatty acids and the metabolism of certain amino acids. They also generate reactive oxygen 
species (ROS), buffer calcium from the cytosol and regulate cell death. Mitochondria have 
their own genetic information in mitochondrial DNA (mtDNA), discovered in the 1960s 
(Nass and Nass, 1963; Schatz, Haslbrunner and Tuppy, 1964; Sagan, 1967; Schwartz and 
Dayhoff, 1978). mtDNA not only provides genetic information, but is also important for cell 
viability. Mitochondria are not only important for their role in energy production, but other 
roles, such as controlling stem cell function and fate are being progressively recognised for 
mitochondria (Folmes et al., 2012). In addition, a metabolic change from glycolytic to 
oxidative, as well as the regulation of the mitochondria permeability transition pore (mPTP), 
are both necessary to achieve embryonic cardiomyocyte maturation (Hom et al., 2011). It 
has been shown that mutation in mtDNA causes diseases (Holt, Harding and Morgan-
Hughes, 1988; Wallace et al., 1988), triggers carcinogenesis (Carew and Huang, 2002; 
Petros et al., 2005) and is related with the apoptosis process (Kroemer and Reed, 2000). 
The accumulation of these mutations results in premature aging in mice (Trifunovic et al., 
2004). 
In mitochondria, energy is produced through mitochondrial oxidative phosphorylation 
(OXPHOS). Glucose is converted into two pyruvates and thus reduces two cytosolic NAD+ 
to NADH and produces two ATP molecules. Next pyruvate enters mitochondria and is 
transformed into Acetyl-CoA and CO2 to produce NADH+H
+ and FADH2. Fatty acids are 
also oxidised by beta oxidation to produce acetyl-CoA, NADH+H+ and FADH2. In both 
cases, acetyl-CoA enters the tricarboxylic acid cycle (TCA) and generates more NADH+H+. 
Both NADH+H+ and FADH2 are oxidised by the mitochondrial electron transport chain 
(mETC). NADH releases electrons to complex I by reducing ubiquinone (CoQ) to ubiquinol. 
The different enzymes that use FAD as a cofactor (like Complex II) release electrons 
directly to CoQ to form ubiquinol. Ubiquinol is reoxidised by complex III, which sends 
electrons downhill to cytochrome c (cyt c) and complex IV, and finally to oxygen to produce 
H2O (Fig. 1) (Wallace, Fan and Procaccio, 2010; Enríquez, 2016). 
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Complexes I, III and IV use the energy released by the electron flux to translocate protons 
(H+) from the inner mitochondrial matrix to the intermembrane space (IS). In this way they 
generate an electrochemical gradient, which is also known as proton motive force (p.m.f.) 
and drives ATP synthesis form ADP and Pi by H+-ATPase.  
 
I.2 Mitochondrial morphology 
 
Mitochondria are delimited by two membranes: the inner (IMM) and the outer (OMM). The 
space between both membranes is known as the inner mitochondrial space (IMS), while 
the matrix is located inside the IMM. This morphology was observed for the first time by 
electron microscopy (Palade, 1952; Sjostrand, 1953). The IMM and OMM form different 
sub-compartments that perform specific functions. Thus the OMM forms specialised 
structures that interact with the endoplasmic reticulum (ER), named mitochondria-
associated membranes (MAMs) (Vance, 2014) whose composition differs from other OMM 
areas (Giorgi et al., 2015). In this way there are defined specialised regions in the IMM very 
much enriched in OXPHOS components located in the cristae edge.  
Mitochondrial morphology can switch from an elongated form to a more fragmented status 
due to fusion and fission events and, as a result, the cristae structures in the IMM change. 
These cristae-remodelling processes occur during apoptosis, for example, when 
cytochrome c is released from mitochondria (Scorrano et al., 2002). The morphology of 
these cristae also changes under physiological conditions, in different organs and 
Figure 1. Mitochondrial oxidative phosphorylation diagram (adapted from Wallace, 2005). Glucose 
is converted into pyruvates which enter into the mitochondria and is transformed into Acetyl-CoA 
producing NADH+H+ and FADH2. These two molecules are oxidised by the mitochondrial electron 
transport chain.  
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developmental stages. Mitochondrial fission occurs during the process of eliminating non-
functional mitochondria by mitophagy (Twig et al., 2008), or in the G2/M phase of the cell 
cycle to secure mitochondria segregation during cell division (Smirnova et al., 2001). The 
opposite phenomenon, the fusion process, increases in a different cell cycle phase, G1/S, 
(Mitra et al., 2009), during a starvation period (Rambold et al., 2011) or during embryonic 
development (Chen et al., 2000). 
During development, mitochondria take a simple structure with fragmented cristae and a 
small mtDNA copy number (Folmes et al., 2012; Folmes and Terzic, 2016). 
Cardiomyocytes from E9.5 embryos have fragmented and perinuclear mitochondria, but on 
day E13.5 they extend more into the cytoplasm, and become organised and filamentous 
(Hom et al., 2011). Taken together, all these changes facilitate energy production. 
The morphology of mitochondrial cristae is important from a bioenergetic point of view 
(Cogliati et al., 2013). Cristae increase the IMM surface and the amount of mETC 
(Scheffler, 1999), and it has been proposed that this increases ATP production capacity by 
oxidative phosphorylation (Palade, 1953). Apart from this incremented surface, it is 
believed that cristae also provide a benefit in energy production terms (Cogliati, Enriquez 
and Scorrano, 2016), based on mathematical models (Demongeot et al., 2007), by 
minimising the distance between ADP/ATP translocation and the ATP synthesis site.  
Cardiolipin is an important lipid that determines mitochondrial shape. It is an acidic 
phospholipid found in mitochondrial membranes and its reduction in the IMM has been 
shown to severely alter the mitochondria ultrastructure, as in Barth syndrome (Xu et al., 
2006; Chicco and Sparagna, 2007). Cardiolipin has also been described to estabilish the 
supercomplexes of mETC (Pfeiffer et al., 2003; McKenzie et al., 2006), and the III2+IV2 
association is unstable in its absence (Mileykovskaya and Dowhan, 2014).  
Another protein involved in cristae remodelling is Opa1, optic atrophy type 1 protein, a 
dynamic-like GTPase whose mutations are associated with autosomal dominant optic 
atrophy type I disease (Alexander et al., 2000; Delettre et al., 2000). Processing large 
Opa1 isoforms is essential for mitochondrial fusion (Duvezin-Caubet et al., 2006). There 
are different proteases that control Opa1 cleavage, including Yme1L or Oma1 (MacVicar 
and Langer, 2016).  
The ATPase complex is an important modulator of cristae formation. In Paramecium 
multimicronucleatum mitochondria, ATPase is on the edge of cristae (Allen, Schroeder and 
Fok, 1989). In yeast, ATPase subunits e and g have been reported as non-essential for 
ATP synthesis, but their absence confers a characteristic structure to cristae in the form of 
concentric circles (Paumard et al., 2002). Other subunits, such as ATP6, have been 
described as modulators of ATPase conformation, but are not absolutely necessary for 
cristae formation (Rak et al., 2007; Habersetzer et al., 2013). Another hypothesis that could 
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explain the role of ATPase is that it forms a pH gradient that could lead to a membrane 
curvature that gives rise to cristae formation (Rieger, Junge and Busch, 2014).  
 
I.3 Electron transport chain complexes and their organisation 
 
The OXPHOS system constitutes the most important pathway to produce energy in the cell. 
It is formed by ATPase and four complexes: complexes I, II, III and IV.  
Complex I 
The NADH dehydrogenase complex transfers two electrons from NADH to ubiquinone, and 
is coupled with the translocation of four protons from the matrix to the IMS. It is composed 
of 44 proteins with a weight of 960kDa, of which seven are codified by mtDNA. Recently, its 
structure has been resolved by cryoelectronmicroscopy with a resolution of 4.2 Å in bovine 
mitochondria (Fiedorczuk et al., 2016; Zhu, Vinothkumar and Hirst, 2016). Complex I is 
formed by three different modules: N, that links NADH and oxidises it; Q, that transfers 
electrons to CoQ; and P, the hydrophobic module in the IMM involved in proton pumping 
(Fig. 2A). 
 
 
 
Complex II 
Complex II, or succinate dehydrogenase, is also an enzyme of the tricarboxylic acid cycle 
that catalyses the oxidation of succinate to fumarate. It transfers electrons from FADH2 to 
ubiquinone. It is located in the IMM, faces the intermembrane space and is composed of 
four subunits: SDHA, SDHB (both make up the catalytic site), SDHC and SDHD (allow its 
location in the IMM) (Hägerhäll, 1997) (Fig. 2B). It is a special complex as it does not pump 
protons, and is the only complex that does not contain any subunits codified by mtDNA.  
Figure 2. Complexes from the mitochondrial electron transport chain. A. Mammalian complex I 
structure. B. Complex II structure (modified from (Bezawork-Geleta et al., 2017). subunits of SDH: 
SDHA (blue), SDHB (green), SDHC (brown), and SDHD (red). C. Complex II structure, modified from 
(Xia et al., 2007). D. Structure and cofactor of mammalian cytochrome c oxidase. The three subunits 
codified in mtDNA are in green (Cox1), pink (Cox2) and blue (Cox3) (modified from: Rich, 2017).  
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Complex III 
Complex III, or cytochrome c reductase, transfers electrons from ubiquinone to cytochrome 
c (Fig. 2C). This process is coupled with the pumping of four protons to the IMS. It is 
composed of 11 subunits, of which only one, mtCytb, is codified by mtDNA (Iwata, 1998). 
 
Complex IV  
Complex IV, or cytochrome c oxidase, is the last of the complexes of the mETC. Its function 
is to transfer electrons from cytochrome c to molecular oxygen by generating H2O. Four 
protons are translocated during this reaction. This complex is formed by 14 subunits, three 
of which form the catalytic core, and are encoded by mtDNA, Cox1, Cox2 and Cox3 (Fig. 
2D).  
 
Complexes organisation  
The organisation of the mETC in the IMM has been a matter of debate for decades. In the 
1950s the “solid model” was proposed by Keilin and Hartree to explain the organisation of 
mitochondrial complexes (Keilin and Hartree, 1947). This model described the complexes 
joined as one to act as static entities to secure communication among them (Slater, 2003). 
The “solid model” was questioned after the isolation of active individual complexes took 
place (Hatefi et al., 1962). Moreover, the description of the mobility of coenzyme Q 
between CII and CIII went against the proposed “solid model”.  
A new model, namely the “fluid model”, was described in 1986 by Hackenbrock and 
colleagues (Hackenbrock, Chazotte and Gupte, 1986). This model stated that complexes 
could diffuse into the IMM in an aleatory manner. Electron transport was described as a 
random collision between complexes that depended on the velocity of coenzyme Q and of 
cytochrome c diffusion  
In 2000, the “supercomplexes” structures were discovered by native electrophoresis, Blue 
Native gel (BN-PAGE) (Schägger and Pfeiffer, 2000). BN-PAGE allowed the discovery of 
the stable associations among OXPHOS complexes. The largest form of supercomplexes 
is formed by the I+III2+IV association, known as the respirasome. Other frequent 
associations are the I+III2 supercomplex and III2+IV. Although these associations also exist 
in plants, they can vary in the stoichiometry (Eubel, Heinemeyer and Braun, 2004). As 
example, in Saccharomyces cerevisiae, since they lack complex I, the only supercomplex 
observed was III2+IV2 (Schägger and Pfeiffer, 2000). The largest amounts of these 
supercomplexes are found in mammals such as mouse, bovine or human.  
Based on evidence that favours the two previous models, (Boekema and Braun, 2007; 
Lenaz and Genova, 2007), a new model was proposed, known as the “plasticity model” 
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(Acín-Pérez et al., 2008), which combines the possibility of finding complexes, and not only 
those associated among them, but also individually. 
The I+III2 supercomplex from Arabidopsis thaliana was the first to be investigated by 
cryoelectronmicroscopy techniques (Dudkina et al., 2005). In 2016, three independent 
groups simultaneously provided respirasome structures with significantly improved 
resolution (Gu et al., 2016; Letts, Fiedorczuk and Sazanov, 2016; Wu et al., 2016). 
Sazanov (Letts, Fiedorczuk and Sazanov, 2016), and the Kühlbrandt groups (Sousa et al., 
2016) provided a resolution of 5.8 Å or 9 Å, respectively, from bovine heart. The Yang 
group provided a resolution of up to 4 Å from porcine mitochondria and human 
mitochondria. These groups also provided details of two different respirasome 
conformations, “tight” and “loose”. In a tight conformation, complex IV comes into contact 
with both complex I and III, whereas in a loose conformation complex IV comes into contact 
only with complex I (Letts, Fiedorczuk and Sazanov, 2016).  
The stability of supercomplexes is influenced by different proteins, and also by other non-
protein factors. The first proposed proteins were Rcf1 and Rfc2 in S. cerevisiae (Chen et 
al., 2012). The deletion of these proteins suppresses supercomplexes formation because it 
impairs the association between CIII and CIV. Currently, it seems that these factors are in 
fact directly involved in the assembly of CIV, and indirectly impact supercomplex formation 
through CIV assembly alterations (Garlich et al., 2017). Therefore, they cannot be 
considered specific factors for supercomplex assembly.  
The only bona fide assembly factor described to date is COX7A2L, or SACF1, which 
denotes the name of “Supercomplex Assembly factor 1”. SCAF1 is a protein of 113 amino 
acids, including the mitochondrial import sequence. A mutated version of SCAF1 has been 
described in a subset of inbred mouse strains, notably all investigated C57B/L6-derived 
substrains (Lapuente-Brun et al., 2013). This mutated form of 111 amino acids has an 
intramolecular microdeletion which causes the loss of two amino acids that render it unable 
to interact with complex IV (Cogliati et al. 2016). The mechanism of interaction between CIII 
and CIV is determined by the interchange of the structural subunits of CIV that determine if 
this complex associates with CIII2, dimerise-forming CIV2 or remains as monomer CIV. 
These proteins are COX7A1, which favours CIV dimmer formation, COX7A2 that favours 
CIV monomers, and COX7A2L or SCAF1 that allows the physical superassembly between 
complexes III2 and IV. Additional tissue-specific isoforms modulate CIV dimerisation: 
COX6A2 or COX6A1 (Cogliati et al., 2016).  
Apart from these protein factors, other components, such as cardiolipin, also regulate the 
supercomplexes assembly (Pfeiffer et al., 2003). This phospholipid is important for 
membrane potential maintenance (Gohil et al., 2004). Cardiolipin-deficient cells show the 
instability of the III2+IV2 supercomplex (Pfeiffer et al., 2003). 
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The regulation of supercomplexes formation and their plasticity is important to substrate 
adaptation and optimised mitochondria metabolism. The assembly of CIII and CI generates 
two independent pools of coenzyme Q for the electrons from both NADH and FADH2 by 
avoiding substrate competition in the mETC (Lapuente-Brun et al, 2003; Guaras et al, 
2006).  
The organisation of complexes in supercomplexes is an important issue during embryo 
development in mice. The assembly of supercomplexes around stage E11.5 of embryo 
development has been shown to correspond to a cardiac development step (Beutner, 
Eliseev and Porter, 2014), which indicates that mitochondrial regulation is also important 
during cardiac maturity (Menendez-Montes et al., 2016).  
 
II. ATP SYNTHASE 
 
II.1 F1FO-ATPase structure  
 
The F1FO-ATPase complex is formed by 16 proteins (Collinson et al., 1994) and is located 
in the membranes of different structures, including mitochondria, chloroplasts or eubacteria. 
The general shape of the complex is similar in all three. F1FO-ATPase is composed of three 
domains, the F1, FO and the slender stalk that links all the domains together. The F1 domain 
is extrinsic to the membrane, which is where ATP is produced and hydrolysed. The FO 
domain is embedded in the membrane and forms the channel that allows protons to pass 
through the membrane and to couple it with ATP synthesis. Initially the slender stalk was 
considered an artifact, until it was defined by electron microscopy in Escherichia coli 
(Gogol, Lücken and Capaldi, 1987) (Fig. 3). Later, it was demonstrated that if this stalk was 
disrupted, the F1 domain would be released as a globular complex.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Analysis of the electron microscopy images of ATPase from Escherichia coli. The 
average of the different side views of F1 and FO computed from (A) 30 particles aligned by correlation 
methods; (B) 10 particles with a cleft in the F1 domain; (C) 10 particles with a solid F1 domain.  
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The F1 domain is comprised of five globular proteins, α, β, γ, δ and ε in a specific 
stoichiometry α3β3γ1δ1ε1 with a weight of 350kDa (J.E.Walker et al., 1985; Abrahams et al., 
1994; Collinson et al., 1994). Subunits α and β are arranged in an alternating conformation, 
which generates a spherical structure with a diameter of 100 Å. This structure envelops 
subunits γ that are localised in the central block by fixing these subunits to the FO domain. 
Subunits δ and ε contribute to this association by binding to the end of the cylinder form by 
c subunits (Fig. 4).  
 
 
The FO domain´s name is attributed to oligomycin because is the domain that confers 
sensitivity to this antibiotic (Racker, 1963; J. Symersky et al., 2012). FO is composed of 
subunits a, b, c, d, e, f, g, and A6L in the membrane domain. The c-subunits form a ring 
with different numbers of subunits depending on the species. In bovine mitochondria, the 
number of c-subunits is 8, and is 10 in yeast (Jindrich Symersky et al., 2012). 
 
Other ATPase subunits form the central stalk, or stator, whose function is to fix F1 during 
rotation in order to provide structural sustenance. It is composed of the oligomycin-sensitive 
conferring protein (OCP), and subunits b, d and F6. The structure of these proteins is of 
low-degree conservation between species, but their function is very well conserved. 
 
There are other subunits that form part of ATPase, but their role is not yet well-defined. The 
f subunit, essential for ATP synthesis, produces the phenotype of uncoupled ATP synthase 
when it is lost (Spannagel et al., 1997). Subunit i has been described only in yeast ATPase, 
and it produces the dissociation of the ATPase complex when it is absent. Although 
subunits e, k, and g are involved in dimer formation, the only essential subunit for this 
process is e (no protein homologous to subunit k in yeast has been described in 
mammals). 
Two new peptides have been recently discovered, proteins MLQ and AGP. MLQ is a 
6.8kDa mitochondrial proteolipid, MP68 (Terzi et al., 1990; Chen et al., 2007; Meyer et al., 
Figure 4. Organisation of protein subunits in mitochondria ATP synthase (from (Walker, 2013)). 
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2007), and AGP is a diabetes-associated protein found in insulin-sensitive tissue (DAPIT) 
(Päivärinne and Kainulainen, 2001) (see Section II.6).  
There are some particular situations, such as Rho0 cells, whose lack of mtDNA causes 
distinct ATPase organisation. These cells do not have subunits a and A6L encoded by 
mtDNA, and when the ATPase is resolved in a BN gel, the ATPase complex is not 
observed even though a subcomplex formed by F1-c is detected. Furthermore, peptides 
DAPIT and 6.8kDa protein (MP68) have not been detected by mass spectrometry in these 
cells, which indicates the possibility that these proteins may be involved in the ATPase 
complex assembly.  
 
II.2 ATPase dimerisation  
 
ATPase was first isolated in a monomeric form with 16 proteins. Next the dimeric and 
oligomeric forms of ATPase were described by using different detergents, such as 
digitonine (Krause et al., 2005). With a detergent at a low concentration, after resolving in a 
gel under native conditions, ATPase is observed in different conformations, e.g., 
monomeric, dimeric, tetrameric and hexameric. 
ATP synthase dimers were first identified in yeast (Arnold et al., 1998). The protein 
composition in monomeric and dimeric ATPase forms do not appear to be the same as 
there are three dimer specific subunits, e, g and k, which are not essential for ATPase 
enzymatic activity. The deletion of the g gene is not essential for ATPase dimerisation, but 
the morphology of cristae dramatically changes and mitochondria become enlarged (Giraud 
et al., 2002; Paumard et al., 2002). More recently, the dimeric F1FO-ATPase structure has 
been observed in yeast and is necessary to cause membrane bending to form cristae 
(Hahn et al., 2016) (Fig. 5). Moreover, larger ATPase assemblies have been identified by 
the BN-PAGE technique (Krause et al., 2005; Wittig and Schägger, 2005). 
 
 
 
 
Figure 5. Schematic representation of ATPase dimerisation. ATPase dimers determine the 
curvature of the inner mitochondrial membrane (modified from (Chinopoulos, 2017)).  
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In physiological contexts, ATPase dimerisation is also important during ageing. In mature 
cells, the proportion of dysfunctional mitochondria is higher than in young cells. These 
mitochondria also display a vesicular morphology that lacks cristae, and ATPase dimers 
dissociate into monomers (Daum et al., 2013).  
As described in Section I.2, ATPase plays an important role in cristae formation, promoting 
cristae morphology maturation. In line with this, ATPase is important during germ cell 
differentiation in Drosophila, and not because of its role in energy production, but because 
of the function it performs in cristae formation (Teixeira et al., 2015).  
 
II.3 ATP synthesis 
 
The catalytic ATPase site has been described based on X-ray images from bovine 
(Abrahams et al., 1994) and yeast F1FO-ATPase. As the γ subunit assembly takes place 
asymmetrically, ATPase takes an asymmetric structure and can be observed in different 
conformations. While the central stalk rotates, ATPase can be found in three varying 
conformations of the β-subunit, which confers different catalytic properties (Fig. 6). 
Although conformations βTP and βDP take similar structures, they exhibit differential 
preference in binding nucleotides. While βTP can bind MgAMP-PNP (a non-hydrolysable 
analogue of ATP), βDP binds MgADP. Conformation βE, also known as “open” or “empty”, 
takes a different structure due to the γ-subunit, and is unable to bind any nucleotide. This 
latter conformation is the active one, which releases the ATP molecule.  
 
 
During ATP synthesis, the direction of c-ring cylinder movement is right-handed and this 
rotation is generated by a p.m.f. at a speed of 100-150 rev/s. During ATP hydrolysis, 
Figure 6. Structure of the F1 domain of bovine ATPase (modified from (Walker, 2013)). A. Catalytic 
F1 with the three different conformations. After each rotation of 120º, a conformation change occurs. B. 
State represented by conformation βTP with affinity to Mg-AMP-PNP. C. Conformation represented by 
the presence of βDP, with affinity to Mg-ADP. D. State without any affinity to nucleotides, characterised 
by βE. It is the active conformation.  
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however, the rotation direction reverses. This rotation is produced by the interaction with 
protein a, and the 360º rotation prompts the synthesis of the 3 ATP molecules.  
 
II.4 F1FO-ATPase regulation 
 
F1FO-ATPase activity depends on the energy available in cells. When the proton gradient is 
low, the β-subunit binds MgADP by assuming a conformation that render the complex 
inactive. Other molecules inhibit ATP synthesis, such as ATPase inhibitory factor 1 (IF1). At 
a pH of 6.7, it forms a complex with ATPase that both inhibits ATP synthesis and prevents 
ATP hydrolysis. IF1 is also regulated by post-translational modifications, specifically by 
phosphorylation, which controls the ATPase function in different contexts depending on 
substrate availability or the energy demanded by the cell (García-Bermúdez, Cuezva and 
Bernardi, 2016; Esparza-Moltó, Nuevo-Tapioles and Cuezva, 2017). 
 
II.5 Role of ATP synthase in apoptosis 
 
The apoptosis process occurs when cells die in a programmed manner. It is an energy-
consuming process that takes place in events like cell turnover, embryo development or 
cell death caused by toxic agents (Elmore, 2007). During apoptosis, the permeabilisation of 
the IMM occurs and apoptotic factors are released from the mitochondria to the cytoplasm. 
The structure that would lead to the release of these factors is known as the mitochondrial 
permeability transition pore (mPTP) (Rasola and Bernardi, 2007; Kwong and Molkentin, 
2015). The mPTP is a structure located in the IMM and is permeable to solutes and ions 
and, specifically, the release of calcium and cytochrome c triggers the apoptosis process 
(Eskes et al., 1998). 
The “permeability transition” concept was proposed for the first time by Haworth and Hunter 
(Hunter and Haworth, 1979), but its physiological role and composition have been debated 
for some time. Initially it was suggested that the adenine nucleotide translocator (ANT) is 
involved in mPTP formation because of the inhibition of the mPTP by adenine nucleotides. 
The use of genetic tools to knockout ANT has demonstrated that this hypothesis is 
incorrect, and that ANT is not essential for mPTP formation. A similar situation occurs with 
the Vdac complex; nor does it participate in mPTP regulation (Halestrap, 2009). 
It is believed that ATP synthase is required for mPTP formation (Giorgio et al., 2013) and 
ATPase dimers have been proposed as the mPTP. The purification of these dimers retains 
mPTP activity (Giorgio et al., 2013). Moreover, their role in calcium release in Drosophila 
(Von Stockum et al., 2015) has been demonstrated and suggests that the process is not 
exclusively mammalian (Azzolin et al., 2010). Alternatively, it has been proposed other 
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mPTP identity independently of ATPase dimerisation. In this hioptesis, it is describd the c-
ring subunit of ATPAse as the mPTP (Alavian et al., 2014).  
Currently, the composition of the mPTP remains unclear. Different studies have raised 
doubts about the proposed models. The idea that c-ring forms the mPTP has been ruled 
out using atom molecular dynamic simulations (Zhou et al., 2017). More recently, the belief 
that the peripheral stalk and c-subunits are required to retain mPTP activity has been 
excluded (He, Carroll, et al., 2017; He, Ford, et al., 2017).  
 
II.6 New peptides associated with ATPase 
 
DAPIT and MP68 have remained undetected for a long time. Experimental conditions were 
important to detect them. When exogenous phospholipids are absent, the small proteins 
are lost during chromatography, but if the preparation includes some phospholipids, DAPIT 
and MP68 are found in the purified ATPase complex. Peptides DAPIT and MP68 have 
been identified with sequences AGPEADAQFHFTGIKKYFN and 
MLQSLIKKVWIPMKPYYTQAYQEI, respectively (Fig. 6). Both have been detected in mass 
spectrometry experiments (Rexroth et al., 2004; Chen et al., 2007), in the monomeric and 
dimeric forms of the bovine ATPase complex (Meyer et al., 2007; Nůsková et al., 2015), 
and as individual proteins. The same study found no differences in the hydrolysis capacity 
of ATPase when MP68 was dissociated. Both share a common transmembrane region 
(Fig. 7) and several phosphorylation sites which have not been confirmed by a proteomic 
analysis (Carroll, Fearnley and Walker, 2006). 
 
 
Figure 7. Alignment and structural analysis of proteins MLQ and AGP. The transmembrane region 
is marked in red, phosphorylation sites are marked in blue, and green and yellow denote the unmarked 
amino acids, which are identical, similar and non-similar. A. Alignment of the DAPIT sequence from R. 
norvegicus (R.n.), Bos taurus (B.t.) (gi91207977), Homo sapiens (H.s.) (gi 14249376), and S. bullata 
(S.b.) (gi23505740). B. Alignment of the MP68 sequence from R. norvegicus (R.n.), Bos taurus (B.t.) 
(gi91207977) and S. bullata (S.b.) (gi23505740) (modified from (Meyer et al., 2007).  
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These two peptides were initially attributed to peripheral functions, but then more important 
roles were ascribed to them when they appeared in a screening of regulators of oxidative 
phosphorylation (Baughman et al., 2009). In the screening, for which shRNAs were used, 
more than 85% of mRNA levels were depleted and the oxygen consumption rate (OCR) 
was measured. No alterations in the OCR were observed in either the shRNA of the Dapit 
and Mp68 cells, or in the expression levels of other proteins of the mETC, including 
NDUFB8, SDHB or ATP5a. Although DAPIT and MP68 were proposed as the principal 
candidates to interact with mETC genes, changis in the oxidative phenotype in these 
mutants was not observed. 
 
The interactions between the subunits of the ATPase complex, more specifically those 
involving DAPIT and MP68 have been analysed in covalent cross-linking assays. DAPIT 
and MP68 protein, as well as other peptides including ATP8, e, f, or g, have been 
described as supernumerary subunits. Nonetheless, this has not been confirmed by gel 
staining intensity where all the ATPase subunits have been resolved (Lee et al., 2015). 
Lysine K49, in the carboxyl terminal of MP68, is linked to the same region of DAPIT K55, 
and also to different lysines of supernumerary subunits e, f or g (Fig. 8). 
 
 
 
Recently, the three-dimensional structure of a new ATPase domain has been observed in 
cryo-electron microscopy (cryo-EM) images and by a computational analysis (Fischer et al., 
2017). It is named the intermembrane space domain (IMD), and is described as a new 
domain associated with the traditional FO ATPase complex, but is clearly separated.  
 
 
The presence or absence of the IMD determines state 1 or state 2 of the ATPase structure, 
respectively (Fig. 9A). The IMD was identified in individual particles associated with 
ATPase that come into contact with the rotor region (Fig. 9B), and its structure is divided 
Figure 8. The cross-links detected between some ATPase subunits. The residues that cross-link 
between the supernumerary subunits of ATPase are shown in the figure (from (Lee et al., 2015)).  
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into a tubular domain, SD1, and a globular domain, SD2 (Fig. 9C). In the particle where the 
IMD is absent, the transmembrane region remains unaffected, which indicates that the IMD 
does not play a role in membrane bending (Fig. 9D).  
 
 
 
The absence of DAPIT and MP68 in stage 2 led to the conclusion that the IMD is formed by 
them, supported by the fact that strong interactions with other ATPase components were 
lacking, and also by their absence in preparations with small amounts of phospholipids. 
Furthermore, different structural models were proposed using the IMD structure and the 
previous cross-linking analysis, which concluded that these two proteins are the only 
candidates that occupy the IMD space (Fig. 10A-C). 
 
Figure 9. Description of FoF1 ATP synthase with and without an intermembrane space domain 
(IMD). A. After a computational analysis of the cryo-EM images, an IMD was described to be slightly 
associated with bovine ATPase. Two groups of structures are separated, state 1 where an IMD is 
present, and state 2 where an IMD is absent. B. The IMD is located in the inner mitochondrial space 
(IMS). C. The IMD structure with two domains: SD1 (tubular) and SD2 (globular). D. The IMD is not 
essential for membrane bending. From (Fischer et al., 2017). 
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Similar IMD structures were found in other ATP synthases from yeast or ciliates, but their 
shape differed. The common aspect of these three cases was that the IMD always came 
into contact with the rotor region, which indicates its importance in regulating its function or 
its structure. The interaction between the IMD and the c subunits could affect the function 
of ATPase; in this scenario, the IMD would act as an inhibitor of FO (similarly to IF1 in F1). 
Nonetheless, the function performed by the IMD did not come over very clearly, and one 
suggestion is that it may be involved in the regulation of the mPTP opening monitored by 
either a lipid plug or dimer formation. 
 
DAPIT (AGP)  
 
DAPIT (diabetes-associated protein in insulin-sensitive tissue) is a basic hydrophobic 
protein that is 58 amino acids long with a single transmembrane helix. Its C-terminal 
domain is located in the intermembrane space (IMS) (Lee et al., 2015) (Fig. 11).  
Figure 10. Structural composition of the mammalian IMD. A. Representation of state 1 of the IMD. 
The F1 domain is depicted in grey, the c-ring rotor of ATPase is shown in blue, subunit a in purple and 
subunit b in magenta. B. Model of subunits DAPIT MP68 obtained by iTasser. C. Modelling DAPIT and 
MP68 in the IMD. Yellow spheres indicate the residues involved in cross-linking. From (Fischer et al., 
2017). 
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Figure 11. Conservation of the DAPIT protein sequence in metazoans. The sequence of DAPIT 
proteins of several organisms appears with this colour code: pink, hydrophobic; orange, aromatic; blue, 
basic; red, acidic; green, hydrophilic; magenta, proline and glycine. Yellow denotes cysteine residues. 
From (Lee et al., 2015).  
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This peptide has been described in a streptozotocin-induced diabetes rat model 
(Päivärinne and Kainulainen, 2001). Streptozotocin (STZ) is an antibiotic, an analogue of 
glucose molecules that induces diabetes type I. STZ enters the beta cells of the pancreas 
by specific transporter GLUT2, which is enriched in this cell type. Therefore in this model, a 
high DAPIT mRNA expression was detected in tissues such as the brain, skeletal or 
cardiac muscle, but levels were lower in other tissues like the lung, liver or kidney. 
Following STZ treatment, Dapit mRNA decreased in the diabetic rat compared to the 
control ones. For this reason, the detected ORF was called DAPIT, diabetes-associated 
protein in insulin tissues. The DAPIT protein has been highly conserved during evolution. 
The human protein has a 58-98% similarity to proteins Fugu and Xenopus, and shares 
40% identity with Drosophila melanogaster homologous protein Neb-cGP. In all these 
species, it is noteworthy that 13 amino acids are conserved, which indicates their potential 
importance in the DAPIT structure or function (Päivärinne and Kainulainen, 2001).  
Given its general expression pattern, it was initially considered to perform a general 
function. In particular, insect homologue Neb-cGP has been described as a stimulator of 
cAMP. According to these data, DAPIT may be involved in this process under diabetic 
conditions (Päivärinne and Kainulainen, 2001).  
HeLa cells with low DAPIT levels, by shRNAs, show loss of the ATPase population in 
mitochondria at the protein level, but not mRNA (Ohsakaya et al., 2011). They also present 
impaired ATP synthesis and cell growth. In these cells, these authors did not observe any 
disassembly of ATPase or supercomplexes.  
With the human cells that overexpress the DAPIT protein, glucose metabolism modulation 
has been observed (Kontro et al., 2015). In these cells, the mtDNA content and 
mitochondrial mass lower, while the mitochondrial membrane potential increases. A 
tendency towards glycolytic metabolism has been detected, which promotes the activation 
of HIF1alpha in Wnt/beta catenin signalling.  
 
6.8kDa protein (MP68) 
This protein has been described simultaneously to the DAPIT protein (Terzi et al., 1990; 
Chen et al., 2007; Meyer et al., 2007). Although the interference of the Mp68 gene in cells 
reduces both the ATPase population and ATP production (Fujikawa et al., 2014), the 
mRNA levels of the main ATPase subunits remain unaffected.  
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III. METABOLIC CONTROL BY OPTOGENETICS  
 
III.1 Optogenetics systems 
 
Optogenetic tools were traditionally used to modulate signalling in cells, whereby light 
induces conformational changes to proteins by triggering a cellular response. Initially, light-
sensitive channels were developed to modulate the polarity of neurons to thus initiate a 
signalling pathway (Zemelman et al., 2002). Beyond the neuroscience field, optogenetic 
applications are broader, and optogenetics is also used to manipulate gene expression 
(Yazawa et al., 2009; Kennedy et al., 2010) and to modulate the behavior of individual cells 
for example, by modifying cell polarity. The commonest method to do this is by modulating 
protein dimerisation with light (Levskaya et al., 2009; Guglielmi, Falk and De Renzis, 2016). 
By way of example, changing the conformational status of proteins to produce an active 
protein is used to photoactivate Rac and to control cell motility (Wu et al., 2009). 
 
III.2 Optogenetics in metabolism  
 
These tools have also been used In the metabolism field to modulate gene expression and 
to modify and study metabolism (Idevall-Hagren et al., 2012; Inglés-Prieto et al., 2015). All 
these examples use light as a trigger to induce conformational change. However, the 
possibility of using optogenetic systems to convert light energy into energy that can be 
used by cells to grow has been explored only minimally. 
 
III.3 Deltarhodopsin  
 
The first described microbial rhodopsine was in Halobacterium salinarun (Grote and 
O’Malley, 2011), but later others were found in several species. They all share a structure 
determined by seven transmembrane helices and they perform different functions as light-
driven protons, ions or photosensors (Lanyi, 1998) (Fig. 12). 
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More specifically, Deltarhodopsin (HtdR) is a light-driven proton (H+) pump present in the 
membrane of Haloterrigena turkmenica (Kamo et al., 2006) and others species. Its 
structure in different organisms is similar.  
The functionality of HtdR has been demonstrated in artificial vesicles, which expresses 
HtdR together with FoF1-ATP synthase. HtdR translocates H
+ into vesicles and ATP 
synthase can use the H+ gradient to generate ATP from ADP in the extra-vesicle medium. 
This protein has also been used in cells to partially rescue membrane damage following 
neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment (Hara et al., 
2013). 
 
III.4 Detaching ATP synthesis from the mitochondrial electron transport chain by 
optogenetics 
 
Deltarhodopsin expression in cells is a way to separate ATP synthesis from electron 
transport in the mETC. Previously, this effect was achieved by the expression of other 
proteins, such as Ndi1 from Saccharomyces cerevisiae and Aox from fungi (Perales-
Clemente et al., 2008). Ndi1 is a NADH dehydrogenase with NADH DH/CoQ reductase 
activity that can substitute the function of complex I in yeast, but without H+ pumping. Aox 
is an alternative oxidase present in plants and fungi that is able to oxidase the CoQ. With 
the expression of both these proteins in mitochondrial-deficient cells, it is possible to 
restore the capacity of these mutant cells so they can grow in the absence of pyruvate and 
uridine because they are able to restore the electron flux. Although these two proteins can 
Figure 12. Diagram of the rhodopsin structure of Haloterrigena thermotolerans. Transmembrane 
helices are represented in rectangles, the amino acids with a positive and negative charge are 
depicted in blue and red, respectively. The green circles include the amino acids that interact between 
helices, and the pink circles show the most conserved residues between rhodopsins (from (Zhang et 
al., 2013) 
Introduction 
 
 48
restore the electron flux, they cannot restore proton pumping, which means that these cells 
are unable to grow in galactose. Expressing deltarhodopsin in these cells would allow the 
ETC function to be fully restored.  
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The role attributed to ATP synthase as the main energy producer of the cell has been 
maintained for years. Nonetheless, new functions have been defined, such as a regulator, 
apoptosis or as a determinant of mitochondrial cristae morphology. For this reason, the 
structure of this complex has been studied in detail, which led to the discovery of new 
subunits associated with it. We are interested in characterising these new subunits and 
their role in the ATPase function.  
 
Optogenetics is a technique that has been traditionally used in the neural field to 
modulate cell behavior. We aim to extend its applications to the metabolism field.  
  
Taken together, the specific objectives of this doctoral thesis are the: 
 
1. Characterisation of proteins DAPIT and MP68 at the structural and functional levels. 
 
2. Modulation of survival in the absence of the functional mETC. 
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I. CELL CULTURE 
 
III.1 Mammalian cells 
 
The following cells were used in this work (Table 1)  
Table 1. The cells used in this work.  
 
Line nDNA mtDNA Mutation ETC Origin Reference 
L929
mtC57 L929 C57BL/6 - 
All 
complexes 
are stable 
Cybrids 
generated by 
transferring the 
platelet of cells 
C57BL/6 to 
ρ
0929  
Moreno-
Loshuertos 
et al. 2006 
ND4
KO L929 3T3 
Mt-nd4 
10227delA 
(homoplastic) 
Complex I 
absent 
Random 
mutation in 3T3 
cells and transfer 
to L929 cells 
Perales-
Clemente et 
al. 2010 
Cox10
KO 129/SvJ C57BL/6 
 
Cox10 knockout 
(homozygosis) 
Complexes 
I and IV 
absent 
Cre protein 
expression in the 
Cox10flox/flox 
fibroblasts 
Diaz et al. 
2006 
 
F3T3 
 
L929 3T3 - 
All 
complexes 
are stable 
Cybrids 
generated by the 
fusion of 
mitochondria 
from 3T3 cells 
with ρ0929 cells 
R. Moreno 
 
III.2 Culture medium 
 
The culture medium used to grow the cell lines was DMEM medium that contained L-
glutamine and glucose at a concentration of 25 mM. The following were also added: 5% of 
FBS, 1mM sodium pyruvate, 100 units/mL penicillin and 100 ug/mL streptomycin. For the 
culture of some mutant cells with deficiencies in the ETC, uridine was added at a 
concentration of 50 ug/mL.  
The medium used in the growth curve (Section I.5) was modified to ensure that other 
components did not interfere with growth, only with the carbon source of glucose or 
galactose. This prepared medium consisted of DMEM (Sigma D5030) in water 
supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate, 5% dialysed FBS, 100 
units/mL penicillin, 100 ug/mL streptomycin and phenol red. Then depending on the 
experiment, the medium was supplemented with 5 mM or 25 mM of glucose or galactose. 
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III.3 Culture conditions 
 
Cells were grown at 37ºC at a constant level of 5% CO2. The medium was frequently 
changed every 48 h, except in the growth curve experiment where the medium was 
changed daily.  
 
III.4 Ectopic gene expression in mammalian cells  
 
To get a stable expression of an exogenous protein a lentiviral infection was used.  
To obtain viral particles, 293T cells were used and transfected with transfection reagent X-
treme-GENE-HO (Roche) following the manufacturer’s instructions. Firstly cells were 
placed in a medium that contained 25 µM chloroquine to avoid degrading exogenous DNA. 
Next 7 µg of the DNA that coded the viral capsid (the psPAX2 vector), 3 µg of the DNA that 
coded the viral envelope (pMD2G) and 10 µg of plasmid pWXLD with the sequence of 
interest were added to the FBS-free medium (Table 2). 
 
Table 2 . Plasmids used to express exogenous proteins in mammalian cells.  
Plasmid Bacterial 
resistance 
Eukaryotes 
promotor 
Eukaryotes 
selection 
Origin Use 
pWXLD ampicillin EF1 alpha puromycin 
TronoLab 
(with some 
modifications) 
Lentiviral vector to 
expression in eukaryotes 
psPAX2 ampicillin CMVeh - TronoLab 
Lentiviral packaging 
vector (2nd generation) 
pMD2G ampicillin CMV - TonoLab Lentiviral envelop vector 
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The produced viral particles were released to the medium and were collected 48 h and 72 
h post-transfection. The medium was filtered with a 0.45 µM filter to eliminate cell debris 
before storing it at -80ºC. A small portion of it was kept to quantify the number of viral 
particles by qPCR (Scherr et al., 2001). After determining the concentration, a particular 
MOI (multiplicity of infection) was selected (1, 5 or 10) as well as the infected cell line. Cells 
were incubated with viral particles for 6 h and were then cultured in normal medium. The 
antibiotic was added to the medium to select the infected cells after 48 h, which allowed 
enough time for the selection gene to be expressed, specifically the puromycin resistance 
gene.  
 
III.5 Growth curve 
 
To determine the ability of the different cell types to grow, a growth curve in the presence of 
glucose or galactose as a carbon source was performed. The cells with mutations in the 
ETC protein cannot survive in galactose medium because its conversion into energy is very 
slow, and glycolysis does not suffice to produce all the ATP required for cells to grow.  
Cells were cultured in p96 plates at a density of around 2000 cells/well (depending on cell 
type). Cell growth was monitored daily by the CyQUANT™ NF Cell Proliferation Assay Kit 
(Thermo Fisher C35006) to measure DNA content. The number of plates depended on the 
experiment time. Typically, 5 days sufficed to evaluate the growth changes in different 
substrates.  
In some experiments, different inhibitors, such as Antimycin a (inhibit complex III), were 
used to examine cell growth in its presence.  
 
III.6 Cell growth in light conditions  
 
To HtdR-expressing cell been an active protein which translocates protons, it is needed a 
source of light. Here, a standard cell incubation was transformed in an illuminated incubator 
thanks to the position of torch into it (Fig. 13). The torch used contains several LEDs that 
provides a whit light without warm up the place. 
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III.7 Immunofluorescence 
 
Immunofluorescence was completed to detect the presence of some proteins. Cells were 
grown in p12 plates on glass covers. Firstly, they were fixed with 4% paraformaldehyde in 
culture medium for 15 minutes at 37ºC. Next they were washed several times with PBS. To 
permeabilise cells, covers were treated with PBS with triton X-100 for 5 min in the same 
plate. A blocking step was used by adding PBS with triton X-100 and 2% BSA for 10 min. 
Finally, the primary antibody was added to the blocking solution to detect the protein of 
interest (Table 3).  
 
Table 3. Antibodies used for immunofluorescence 
Detected antigen Species Catalogue number Company 
HA epitope Rat IgG1 11867423001 Sigma 
Tom20 Rabbit IgG sc-11415 Santa Cruz 
DAPIT Rabbit IgG 17716-1-AP Proteintech 
Ndufa9 Mouse IgG ab14713 Abcam 
 
 
 
 
Figure  13. Photography of the illuminated incubator assembly. The torch was ubicated at the 
top of the incubator and the light illuminates the plates.  
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IV. ANIMAL MODELS 
 
IV.1 Mouse strains 
 
Two mouse strains were generated during this thesis. The first was a knockout for the 
DAPIT protein. The frozen sperm of a Dapit transgenic mouse C57BL/6N-
Usmg5tm1a(EUCOMM)Wtsi/H was obtained from the European Mouse Mutant Archive (EMMA) 
with ID EM:07834 and the following construct (Fig. 14). 
 
 
 
 
This is a very versatile construct. Firstly, Dapit expression could be followed because of 
lacZ expression and its subsequent detection via X-gal staining. Secondly, since it is a 
conditional transgenic mouse, the DAPIT protein could be specifically deleted in different 
tissues depending on the particular cre line used.  
In vitro fertilisation (IVF) of the C57BL/6 female mice was performed at the Transgenesis 
Unit of the CNIC. Descendants were genotyped to select the transgenic line of interest. 
Transgenic mice were then crossed with a flippase mouse line to thus eliminate the neo 
and lacZ cassettes found between the FRT sites. Lastly, in order to achieve full knockout, 
mice were crossed with the Sox2:cre mouse line (Hayashi, Tenzen and McMahon, 2003), 
which expresses cre recombinase under the control of the Sox2 promotor during early 
development.  
The second mouse strain generated was a knock-out of Mp68. In this case, embryonic 
stem (ES) cells were obtained from the European Mouse Mutant Cell Repository 
(EuMMCR). The transgenic ES for the 2010107E04Rik gene (Mp68) was performed in the 
JM8A1.N3 cell line. The basis of the structure of the used construct was the same as the 
transgenic Dapit one, the lacZ cassette, and the codifying exons placed between the loxP 
sites.  
  
 
Figure 14. Scheme of the construction of transgenic mice. The lacZ- and neomycin-resistant 
genes lie between the FRT sites, and the main exons, 2 and 3, lie between the loxP sites (From 
EMMA).  
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IV.2 PCR for genotyping 
 
To genotype mice, a piece of tail was cut from mice during weaning, and DNA was 
extracted using the REDExtract-N-Amp™ Tissue PCR Kit following the datasheet 
indications. Taq DNA polymerase was used to genotype. 
The primers used to genotype the different mouse lines are specified (Tables 4 and 5).  
 
Table 4. Primers to genotype the Dapit transgenic mice 
To genotype the DAPIT mice Sequence 
Wild-type allele 
TGCCAGTTCTTGGCTTACACT 
AAGGCCAGCTAAAGTTGGAG 
Transgenic allele 
TGCCAGTTCTTGGCTTACACT 
GAACTTCGGAATAGGAACTTCG 
Floxed allele 
AAGGCGCATAACGATACCAC 
CCGCCTACTGCGACTATAGAGA 
Knockout allele 
AAGGCGCATAACGATACCAC 
TGGGAAAGCACTTAACCCCA 
 
 
Table 5. Primers to genotype the Mp68 transgenic mice 
To genotype the Mp68 mice Sequence 
Wild-type allele 
GGGAATGTGGGTATCTAGTTTGGT 
 AATGAAGACGGAGGCCTGTT  
Transgenic allele GGGAATGTGGGTATCTAGTTTGGT 
ACTTCGGAATAGGAACTTCGGT 
Floxed allele AAGGCGCATAACGATACCAC 
CCGCCTACTGCGACTATAGAGA 
Knockout allele AAGGCGCATAACGATACCAC 
TAGACAGACAGCCAGTCCCG 
 
V. PROTEIN RESOLVING AND ANALYSIS 
 
V.1 Protein extraction and quantification  
 
Proteins were extracted from cells with RIPA buffer (50 mM TrisHCl pH7.4, 50 mM NaCl, 
1%Triton x-100, 0.5% sodium deoxycholate, 5 mM EDTA, and a protease inhibitor cocktail 
(11697498001 Sigma). Cells from a p100 plate were pelleted and washed with cold PBS 
twice. The pellet was then resuspended in 200 µL of RIPA buffer, incubated at 4ºC for 15 
min and placed on a rotating wheel. Lastly, cells were centrifuged at 15,000g for 15 min at 
4ºC and the supernatant was collected.  
The Bradford method was used to quantify the protein concentration in the samples (Bio-
Rad 5000006) (Bradford, 1976). Next 1 µL of sample was added to each well, which 
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already contained 200 µL of water, and were quantified by triplicate readings. A standard 
protein curve using 0, 1, 2, 3, 4, 5, 10 and 15 µL of 1 mg/mL stock of BSA was used to 
measure the absorbance of the samples. Finally, 50 µL of Bradford reagent were added, 
mixed well and measured in a spectrophotometer at 595 nm. 
 
V.2 SDS-PAGE electrophoresis  
 
Standard denaturing (SDS-PAGE) conditions were used to resolve proteins. A 30% 
percentage of acrylamide/bis-acrylamide (29:1 ratio) (A/BA) was used and they were run in 
gel with stacking and resolving parts (Table 6). 
Table 6. SDS-PAGE gel composition  
 
 Resolving 12.5% Resolving 7% Stacking 
Tris HCl 1M pH 8.8 1.87 mL 1.87 mL - 
Tris HCl 1M pH 6.8 - - 0.25 mL 
A/AB 30% 2.08 mL 1.16 mL 0.33 mL 
Distilled water 1.05 mL 1.94 mL  
SDS 20% 25 µL 25 µL 10 µL 
APS 20% 15 µL 15 µL 10 µL 
TEMED 5 µL 5 µL 5 µL 
 
Samples were run in Tris-glycine buffer (Tris 25 mM, glycine 20 mM and SDS 0.5%) at 10 
mA voltage during stacking, and voltage was raised to 20 mA once the samples reached 
the running gel (if the number of gels was more than 1, amperage was increased). This 
was done with a Mini-PROTEAN Tetra Cell (BioRad).  
 
V.3 Protein transference to a PVDF membrane and protein detection 
 
After resolving proteins on gel, they were transferred to a PVDF membrane (Immobilon-FL, 
0.45 µM) and were then transferred and run in transfer buffer (48 mM Tris, 39 mM glycine 
and 20% methanol) for 1 h and 15 min at 100 volts (V) by the Mini Trans-Blot Cell system 
(BioRad). The membrane was blocked to avoid non-specific unions of antibodies with 5% 
BSA in PBS or with Sea Blocking buffer (Thermo Scientfic 37527) for 1 h at room 
temperature (RT) or o/n at 4ºC. 
To detect specific proteins, the primary antibody was diluted in blocking solution and 
incubated with the membrane for 2 h at RT (Table 7). Next the membrane was washed 3 
times with PBS that contained 0.1% Tween-20 for 5 min. The secondary antibody diluted in 
blocking solution was also added and incubated for 1 h at RT (Table 8). Afterwards the 
membrane was washed once more (the last wash was done only with PBS). 
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To develop the signal, the Odyssey ® Imaging System (from LI-COR Company) was used. 
By this technology, two longitudinal waves were detected at the same time, which allowed 
the simultaneous detection of two proteins of a similar size.  
 
Table 7. Primary antibodies used  
 
Detected antigen Species Code Company 
ACTIN Rabbit IgG A2066 Sigma 
COI Mouse IgG2 459600 Invitrogen 
DAPIT Rabbit 17716-1-AP Proteintech 
NDUFA9 Mouse IgG ab14713 Abcam 
OPA1 Mouse IgG 612606 BD Bioscience 
TOM20 Rabbit IgG sc-11415 Santa Cruz 
UQCRC1 Mouse IgG1 Ab110252 Abcam 
UQCRC2 Rabbit 17716-1-AP Proteintech 
 
 
Table 8. Secondary antibodies used  
 
Detected antigen Conjugation Code Company 
Mouse IgG (H+L) DyLightTM 800 610-145-121 Rockland 
Mouse IgG (H+L) Alexa Fluor 680 A21057 Life Technologies 
Rabbit IgG (H+L) DyLightTM 800 610-145-122 Rockland 
Rabbit IgG (H+L) Alexa Fluor 680 A210766 Life Technologies 
Rat IgG(H+L) IRDye800 926-32219 LI-COR 
Rat IgG(H+L) Alexa Fluor 680 A21096 Life Technologies 
 
 
VI. ANALYSIS OF MITOCHONDRIAL COMPLEXES AND SUPERCOMPLEXES 
 
VI.1 Mitochondria extraction from cells and tissues 
 
Mitochondria isolation was done following the protocol of J.A. Enríquez’s laboratory 
(Fernández-Vizarra, López-Pérez and Enriquez, 2002).  
 
Mitochondria from cells 
To isolate mitochondria from cells, 10 plates of 10 mm were required. Cells were 
trypsinised and then pelleted. The pellet was washed with PBS prior to extraction. At this 
point, the pellet can be stored at -80ºC or directly extracted. In the next step, hypotonic 
medium (sucrose 83 mM, MOPS 10 mM, pH 7.2) was added to resuspend the pellet (seven 
volumes of the pellet volume). After 2 min on ice, the pellet was placed into a glass tissue 
potter and homogenised in a stirrer (Heidolph RZR 2041). Afterwards, the same volume 
was added to the hypertonic medium (250 mM sucrose, 30 mM MOPS pH 7.2). Then it was 
centrifuged at 1,000g for 5 min at 4ºC. The supernatant was collected in several 1.5mL 
phials and centrifuged at 13,000g for 5 min at 4ºC. Next pellets were collected and washed 
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with medium A (320 mM sucrose, 10 mM Tris, 1mM EDTA, pH 7.4) several times and 
placed in a single phial. Finally, samples were quantified by the Bradford method (see 
Section III.1) and stored at -80ºC in 50 mM Bis-Tris, 1M aminocaproic acid at a 
concentration of 10 ug/uL. 
 
Mitochondria from tissues 
 
Instead of using a hypo/hypertonic medium, the mitochondria from tissues were 
homogenised directly in medium A, except when extracting mitochondria from the heart, 
when fatty acid-free BSA was added.  
 
VI.2 Mitochondria samples preparation 
 
Fresh or defrosted mitochondria were lysed with digitonin, a soft detergent at a 
detergent:protein ratio of 4:1 (g/g). Each 10-µL (100 µg of protein) aliquot was treated with 
4 µL of 10% digitonin. The mix was incubated for 5 min on ice and centrifuged at 13,000g 
for 30 minutes at 4ºC. The supernatant was then collected and applied to 3 µL of loading 
buffer (5% Coomassie Blue G-250 in 1M aminocaproic acid).  
 
 
VI.3 Blue-Native PAGE gel 
 
Blue-Native Gel (BN) electrophoresis should be carried out to visualise mitochondrial 
complexes (Schägger, 1995; Wittig, Braun and Schägger, 2006). A gradient gel is required 
to resolve high-molecular-weight complexes (Table 9). Using the gradient, resolving gel 
was prepared in 1.5 mm-thick glass plates with the gradient former connected to a 
peristaltic pump.  
Table 9. BN gel composition 
 
Resolving gel component Acrylamide solution, 3% Acrylamide solution, 13% 
A/BA 48:1.5 0.305 mL 0.866 mL 
Buffer 3x * 1.667 mL 1.111 mL 
Distilled water  3 mL 0.713 mL 
Glycerol 85% - 0.643 mL 
APS 20% 20 µL 7 µL 
TEMED 4 µL 3 µL 
 
* Buffer 3x: Bis-Tris 150 mM, aminocaproic acid 1.5 M, pH 7 
See Section III.2 for the stacking gel composition   
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VI.4 BN-PAGE electrophoresis  
 
Mitochondria samples, already digitonised and containing the loading buffer, were loaded 
onto gels and run in a Mini-PROTEAN Tetra Cell apparatus (BioRad). Different buffers 
were used to run cathode A (50 mM tricine, 7.5 mM imidazole, 0.02% Coomassie blue G-
250, pH 7), cathode B (50 mM tricine, 7.5 mM imidazole, pH 7), and anode (25 mM 
imidazole, pH 7). The first run was at 150V for 40 min using cathode A, with an extra 1 h at 
300V with cathode B (the anode buffer was the same throughout the process).  
To transfer the mitochondria complexes to a membrane, the same protein transfer 
procedure was followed (see Section III.3). 
 
VII. MITOCHONDRIAL ANALYSIS  
 
VII.1 Subcellular fractionation  
 
Mitochondria isolation was done as previously described (see Section Methods IV.1). Fresh 
mitochondria were treated with trypsin to digest he proteins in the OMM, as previously 
described (Perales-Clemente et al., 2011). 
 
VII.2 ATP synthesis 
 
An ATP synthesis measurement was taken in fresh mitochondria. ATP was detected by the 
luciferin/luciferase fluorimetric method that follows this reaction:  
 Luciferase + luciferin + ATP  luciferase-luciferil-AMP + PPi 
 Luciferase-luciferil-AMP + O2  luciferase + oxyluciferin + AMP+ CO2 +hv 
The produced light was proportional to the amount of ATP, with maximal emission in 560 
nm (Vives-Bauza, Yang and Manfredi, 2007).  
Using flat-bottomed white plates (96-well Costar Assay Plates), 160 µL of buffer A (50 mM 
KCl, 25 mM Tris-HCl, 2 mM EDTA, 0.1% BSA, 10 mM KPO4, 0.1 mM MgCl2, pH 7.4) were 
added. Next a standard ATP curve was done to relate the amount of light and the ATP 
concentration by adding 10 µL at varying ATP concentrations (from 0 to 10 mM). To 
calculate ATP production in the experimental samples, 50 µg of mitochondria were added 
(in the 160 µL of buffer A) to each well. Later substrates were added (a 5 µL mix of 6 mM 
DP5 + 5 µL pyruvate/glutamate/malate, depending on the substrate to be evaluated, + 5 µL 
ADP). Three replicates were needed for each sample measurement. Finally, 20 µL were 
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added (0.5 M Tris-acetate, 0.4 mM luciferin, 10 ug/mL luciferase, pH 7.75). After mixing 
well, the plate was measured in a luminometer (Tubo Sirius, Berthold) for 5 min every 20 
sec.  
During the analysis, a regression line was done by correlating the ATP concentration and 
luminescence. Later ATP production was determined as the nmols of ATP produced in 1 
minute per protein amount.  
 
VII.3 Ultrastructural mitochondrial morphology analysis by transmission electron 
microscopy 
 
 
Apex hearts from mice were collected and fixed in 2.5% glutaraldehyde, 4% formaldehyde 
in 0.1 M HEPES buffer for 5 h at 4ºC. After several washes with 0.4 M HEPES buffer, 
samples were postfixed with 1% osmium tetroxide and 3% potassium ferrocyadine in 
distilled water for 1 h at RT. Then samples were washed in distilled water 3 times for 10 
minutes each time. Next they were dehydrated with different percentages of acetone and 
were embedded in a resin (Spurr Low-Viscosity Embedding).  
 
After solidification, blocks were cut in 60-nm sections, mounted on a copper grid and lead 
citrate-stained. Samples were evaluated by JEOL 10-10 electron microscopy with different 
objectives.  
 
  
VII.4 Metabolic test in mice 
 
Glucose tolerance test (GTT) 
The main objective of the GTT experiment was to determine the capacity of the organism to 
clear glucose from blood (Harlass et al., 1991). To carry this out, male mice were subjected 
to starvation conditions for 6 h before the test started (from 8 a.m. to 2 p.m.). Glucose was 
administered via intra-peritoneal injection. The amount of glucose used in this experiment 
was 1.8 g of glucose per kg of mouse weight. Next a small incision was made at the end of 
the mouse tail to obtain a sufficient amount of blood required to measure the glucose 
concentration. Blood glucose levels were measured prior to glucose administration at 15, 
30, 60, 90 and 120 minutes using specific strips (Lite Blood Glucose Test Strips from 
FreeStyle).  
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Insulin tolerance test (ITT)  
The ITT measures glucose levels by monitoring the response to insulin administration. ITT 
was carried out in mice that had fasted for 2 h (from 12 p.m. to 2 p.m.). Insulin was then 
administered by injection at a concentration of 0.75 U/mL. As well as in GTT, blood glucose 
levels were measured with specific strips at 15, 30, 60 and 90 min after insulin 
administration.  
 
 
VII.5 Mitochondrial swelling assay 
 
In isolated mitochondria, swelling occurs due to the large cytosolic amount of proteins and 
other solutes. This event occurs in vitro after opening the mPTP, which is why it is 
commonly used as a measure of mPTP opening.  
Fresh mitochondria were used, 25 µg per sample in 100 µL of mPTP buffer (200 mM 
sucrose, 10 mM HEPES, 5 mM KH2PO4, 10 µM EGTA, pH 7.3). In 96-well glass plates, 
each sample was placed in a well and then measured by a spectrophotometer. A volume of 
750 µM calcium chloride (CaCl2) was added to trigger mitochondrial swelling. 
Measurements were taken every 15 secs for 6 min in a spectrophotometer at A540. A 1 µM 
concentration of cyclosporine A (CsA) was added to half the wells as a negative control to 
avoid mitochondrial pore opening. 
 
VII.6 Immunoprecipitation of and resolving ATP synthase proteins 
 
To isolate proteins from the ATP synthase complex, the ATP synthase Immunocapture kit 
from Abcam (ab109715) was used with some modifications. At least 1 mg of mitochondria 
at a concentration of 5.5 mg/mL in PBS was needed. This mixture was solubilised with 1% 
n-Dodecyl-D-Maltoside (DDM), a non-ionic detergent, to disrupt the external membrane. 
This mitochondrial suspension was kept on ice for 30 min before centrifuging at 13,000g for 
30 minutes at 4ºC. The supernatant was finally collected. 
During centrifugation, agarose beads that contained specific immunocapture antibodies for 
the ATP synthase complex were prepared. They were cleaned with PBS and placed in a 
new phial (all the working steps with beads were done with blue tips cutting the end). The 
previously collected supernatant was added to beads, incubated at 4ºC and left on a 
rotating wheel o/n.   
The following day, samples were centrifuged at minimum velocity to allow beads to lower. 
Beads were resuspended again in PBS with protease inhibitors and 0.05% DDM, and were 
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placed in a 15-mL phial. Washing was done at 4ºC by leaving the phial on the rotating 
wheel for 15 min. This last step was repeated 3 times, and in the last repetition beads were 
transferred to a 1.5-mL phial. To elute proteins from beads, sample buffer (50 mM Tris-HCl, 
20% SDS, 10% glycerol, 1% β-mercaptoethanol, 0.02% bromophenol blue, pH 6.8) was 
added with no medium. The sample buffer was collected and stored at -80ºC. 
To resolve the proteins obtained from the immunocapture, a big gradient gel (10-15%) was 
done using the former gradient (Table 10) in a big glass. Runs were done with the same 
buffer as SDS-PAGE electrophoresis (Section III.2)  
Table 10. Big gradient gel composition  
 
Resolving gel component Acrylamide solution, 10% Acrylamide solution, 15% 
A/BA 29:1 4 ml 3.5 mL 
Separated buffer 4x * 3 ml 1.75 mL 
Distilled water  4.9 ml 1.75 mL 
APS 20% 15 µL 10 µL 
TEMED 5.76 µL 3.36 µL 
 
* Separated buffer 4x: Tis-HCl 1.5 M, SDS 0.4%, EDTA 8 mM pH 8.8 
 
 
Stacking gel component  
A/BA 29:1 1.2 mL 
Concentrated buffer 4x * 2 mL 
Distilled water  4.7 mL 
APS 20% 37 µL 
TEMED 20 µL 
 
* Concentrated buffer 4x: Tis-HCl 0.5 M, SDS 0.4%, EDTA 8 mM pH 6.8 
 
Then to stain proteins, silver staining (PlusOne Silver Staining Kit form GE Healthcare Life 
Science) was done. 
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I. PROTEINS ASSOCIATED WITH H+- ATP SYNTHASE 
    
I.1 Establishment of the mice DAPIT and MP68 knockout colonies  
 
DAPIT knockout mice 
DAPIT is a subunit of mitochondrial H+-ATP synthase, which has been identified very 
recently and whose role in the complex remains unclear. To study its expression pattern 
and role in vivo, a versatile knock-in mouse was established, which can be used as both 
lacZ reporter and conditional knock out from the European Mouse Mutant Archive (EMMA), 
ID EM:07834. 
Following in vitro fertilisation, the obtained animals were crossed with C57BL/6 mice to 
verify the germinal transmission of the transgenic cassette (Fig. 15A). Next, the sequences 
between FRT sites, including neomycin resistance and LacZ genes were deleted by 
crossing the positive descendants with Rosa26:FLP mice, a transgenic mouse line that 
expresses the flipase gene (Fig. 15B). This was done to avoid interfering with gene 
expression levels. In this way, floxed mice were obtained with the codified exons of interest 
between loxP sites. Lastly, in order to obtain the knockout (KO) mice of interest, floxed 
mice were crossed with a Sox2:Cre line to delete the codified exons (Fig. 15C).  
 
 
 
 
 
 
 
Figure  15. Schematic representation of the different transgenic lines of proteins DAPIT and 
MP68. A. Original construct of the transgenic Dapit mouse. B. Representation of an allelic construct 
after crossing transgenic Dapit with a flipase mouse. Neo-LacZ cassette deletion occurred. C. 
Construct was obtained after the crossing with a Cre protein expression mouse line. The exons 
between LoxP sites were deleted.  
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MP68 knockout mice 
To obtain the MP68 knockout mouse, the same strategy was employed as that for the 
DAPIT knockout with specific primers to the genotype (Fig. 15). In this case, ES cells were 
obtained from the European Mouse Mutant Cell Repository (EuMMCR). The transgenic ES 
for the 2010107E04Rik gene (Mp68) was used in the JM8A1.N3 cell line. ES cells were 
used to obtain a C57BL/6 chimera, which was crossed several times until the germinal 
transmission of the transgene was observed. To obtain the KO mice, floxed mice were 
crossed with a Sox2:Cre to generate total KO mice.  
 
Previously to the establishment of mouse colonies, mitochondria isolated from fibroblast in 
culture were used to study the function of the ATPase associated proteins DAPIT and 
MP68. When we analysed the ATPase complex by staining with ATP beta antibody, the 
monomeric form of the ATPase was detected, but no multimeric forms were observed 
(Fig.16). This excludes the use of cells to analyse all the possible conformations of ATPase 
and highlights the importance of using an in vivo model to analyse ATPase 
supercomplexes. For this reason, the remaining experiments were performed with tissue-
isolated mitochondria.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure  16. Blue native of cell mitochondria to analyse the ATPase organization by using ATP 
beta antibody. 
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I.2 Characterisation of DAPIT KO mice 
 
The mice that harboured the original construct (Fig. 15A) constitutively expressed the β-
galactosidase gene under the endogenous Dapit promoter. This allowed us to investigate 
the Dapit expression pattern during embryonic development by staining with X-gal. For this 
purpose, E9.5 and E12.5 embryos were chosen. In the E9.5 embryo, the signal was 
detected in heart. At E12.5, this signal became stronger and extended to other tissues from 
the ventral embryo part (Fig. 17). 
 
  
LacZ staining was then analysed in the E12.5 embryo sections. The signal was detected 
mainly in the heart and the neural system, including retina ganglion neurons (Fig. 18).  
 
Figure 17. X-galactosidase staining of the whole embryo. A. Mouse embryo in the E9.5 
developmental stage staining to detect LacZ expression to follow Dapit gene expression. B and C. The 
mouse embryo that expresses LacZ in the ventral area, and more specifically in heart. Bars, 200 µm 
(A), and 1 mm (B, C).  
Figure 18. X-galactosidase staining in the E12.5 embryo. X-galactosidase staining (blue) 
represents the areas in which the Dapit gene is expressed in this stage. A. Longitudinal plane of the 
E12.5 embryo showing LacZ expression in blue. B and C. Transversal plane of the E12.5 embryo 
showing LacZ expression in blue. D. Longitudinal section of X-galactosidase staining of the embryonic 
heart. E. Transversal section of X-galactosidase staining of the embryonic heart. F. Transversal image 
of the eye embryo (RV: right ventricle, LV: left ventricle, LA: left atrium, GN: ganglion neuron. Scale A-
C 1mm, D-F 250 um). 
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To determine whether the expression levels were maintained during development, adult 
organs were also analysed (Fig. 19). In addition to heart, lacZ staining was also detected in 
the liver, kidney, brain, skeletal muscle and spleen.  
 
 
 
 
 
 
 
I.3 Characterisation of mitochondria and OXPHOS function in DAPIT knockout. 
 
As DAPIT expression was detected at a high level in the heart in different developmental 
stages, DAPIT function was studied primarily in this tissue. To confirm the absence of the 
DAPIT protein in the total KO mice, mitochondrial protein from heart was analysed and 
resolved under denaturalising conditions by SDS gel. However, the available commercial 
antibody did not detect any signal at the expected location (Fig. 20A).  
 
 
Figure 19. X-galactosidase staining of the adult organs of the Dapit transgenic mice (Dapit 
tg/tg). A-F. Whole mount X-galactosidase staining A. heart, B. liver, C. kidney D. brain, E. muscle, F. 
spleen. G-H. Cut organs after X-galactosidase staining. G. Brain slide after X-galactosidase staining. 
H. Heart slide after X-galactosidase staining. I. Liver slide after X-galactosidase staining. 
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A reduction in the total quantity of the ATPase complex in the DAPIT knockdown cell has 
been reported (Ohsakaya et al., 2011). To analyse this, the WT and KO heart and liver 
mitochondria were analysed by Western blot (Fig. 20B). No reduction in ATPase was 
observed in the KO mitochondria compared with the WT, which indicates that lack of 
DAPIT protein did not alter the amount of ATPase in the investigated tissues. This 
observation contrasts with previous reports which have shown that the H+-ATP synthase 
complex in DAPIT knockdown cells reduces (Ohsakaya et al., 2011). 
Next the DAPIT commercial antibody was tested under native conditions. Complex V was 
labelled in the WT sample, but not in the DAPIT KO sample, which revealed an efficient 
deletion of the Dapit allele and the absence of the protein product (Fig. 21). Therefore, the 
commercial antibody only detected DAPIT in its folded form. 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. The SDS gel of tissue mitochondria. Mitochondria from wild-type (WT) and KO heart, 
liver, spleen and brain were analysed by Western blot. A. Using the DAPIT antibody, no signal was 
detected at the expected size of 7kDa, which corresponds to the DAPIT protein. B. Detection of the 
ATPb subunit to calculate the amount of the ATPase complex in mitochondria. Tom20 was used to 
check the quantity of total mitochondria in each sample. 
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To analyse the effect of DAPIT loss of function on the different mETC complexes, the 
mitochondria from the DAPIT KO mice were analysed by BN (Fig. 22). No differences were 
observed in the organisation of complexes I, III and IV between the WT and KO heart 
mitochondria.  
 
Figure 21. The blue native of the mitochondria from the WT and DAPIT KO heart mice. Western 
blotting revealed the absence of the DAPIT protein in the KO mice. Vdac was used as the loading 
control.  
Figure 22. Analysis of the complexes of the heart mitochondria of the DAPIT WT and knockout 
by BN. Different complexes of digitonise mitochondria were analysed. A. The BN of the WT and KO 
mitochondria analysed with a specific complex I antibody that detects the Ndufa9 subunit. B. The 
previous membrane incubated with a specific antibody of complex IV that detected subunit CoI. C. 
Analysis of complex III by the UQCRC2 antibody in the previous membrane. D. Merging of previous 
antibody signals.  
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These results are not heart-specific as they were confirmed in the liver mitochondria (Fig. 
23). 
 
 
 
Next ATPase organisation was analysed. In the WT mice, DAPIT co-migrated with the 
monomeric form of ATPase (Fig. 24). In the DAPIT knockout mitochondria, this complex 
migrated slightly more than in the WT, which suggests that the complex could have a 
reduced mass (Fig. 24A). As DAPIT has been described as a supernumerary subunit of 
ATPase, one possible explanation could be that its absence results in an observed reduced 
size of complex V. Other explanation could be the change in the conformation of ATPase 
complex that alter the migration pattern under native conditions.  
 
A change in ATPase organisation was observed in the DAPIT KO mice (Fig. 24B). In the 
WT mice, a high-molecular-weight band was observed that corresponded to ATPase in its 
dimeric form, but it was not observed in the DAPIT KO mice. This result indicates that 
DAPIT is necessary for ATPase dimer formation. 
 
An additional lower-molecular-weight band was observed (Fig. 24A). This band was also 
stained with the anti-beta subunit antibody located in the ATPase F1 domain. The molecular 
weight of this band was estimated to be between 400 and 500 kDa. This ruled out the 
possibility that this band corresponded to the F1 domain, whose weight was estimated as 
350 kDa.   
Figure 23. Analysis of the complexes of the liver mitochondria of the DAPIT WT and knockout 
by BN. Different complexes of digitonised mitochondria were analysed. A. The BN of the WT and KO 
mitochondria analysed with a specific complex I antibody that detected the Ndufa9 subunit. B. The 
previous membrane incubated with a specific antibody of complex IV that detected subunit CoI. C. 
Analysis of complex III by an UQCRC2 antibody in the previous membrane. D. Merging of previous 
antibody signals. 
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A similar result was detected in the DAPIT knockout mice liver. However, the ATPase 
dimers and the F1 domain were not so clearly detected, which made it difficult to analyse 
this phenotype in the liver mitochondria (Fig. 25).  
 
Figure 24. Analysis of Complex V of the heart mitochondria of the DAPIT WT and KO by BN. A. 
ATPase complex detection. B. DAPIT detection in the WT and KO heart mice mitochondria. C. Merging 
of the signal detected with the DAPIT and ATP subunit beta antibodies.  
Figure 25. Analysis of Complex V of the liver mitochondria of the DAPIT WT and knockout by 
BN. A. DAPIT detection in the WT and KO heart mice mitochondria. B. ATPase complexes detection. 
C. Merging of the signal detected with the DAPIT and ATP subunit beta antibodies.  
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Further antibodies were used to confirm the identity of the ATPase subcomplex detected in 
the DAPIT KO mitochondria (Fig. 26). The alpha subunit, which is present in the F1 domain 
of ATPase, was detected in that band (Fig. 26B). However, the ATP5I protein, which 
pertains to subunit F0, was not detected in the studied subcomplex (Fig. 26D).  
 
 
 
 
 
Then, the functionality of the ATPase subcomplex observed in DAPIT KO was evaluated by 
in gel activity. It was demonstrated that at least hydrolytic capacity remained in that 
subcomplex (Fig. 27). 
 
Figure 26. Analysis of the heart mitochondria complexes by BN. A. DAPIT protein detection in the 
heart mitochondria. B. Analysis of the ATPase complexes using an ATP alpha antibody. C. Merging of 
previous antibody signals. D. Another BN gel to analyse the ATP complex by an ATP5I antibody. 
Figure 27. Functional analysis of the ATPase subcomplex in the DAPIT KO heart mitochondria. 
A. In the gel activity of complex V using ATP as a substrate of the reaction. B. Western blot detection 
of the ATPb subunit in a parallel running gel. C. The previous membrane detected the DAPIT protein. 
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To exclude the possibility that these results were caused by the specific detergent 
concentration, a digitonin/protein proportion effect was evaluated. The ATPase subcomplex 
was detected independently of the amount of detergent used, which indicates that it is not a 
technical artifact, but is present in cells instead (Fig. 28). 
 
 
 
 
 
Thus DAPIT, apart from being implicated in the dimerisation of ATPase, is necessary for 
ATPase monomers stability. In the absence of DAPIT, a 400-500 KDa subcomplex that 
contained the alpha and beta, but not the e, subunit was dissociated. All these results 
strongly suggest that it could correspond to the subcomplex identified in the Rho0 cells 
composed of at least subunits α, β, and γ1 from F1, and subunit c from FO (Nijtmans et al., 
1995). 
 
 
The relationship between the different ATPase peripheral subunits is not clear. To better 
understand this, the ATPase structure in Rho0 cells was analysed. These cells have no 
Figure 28. Digitonine curve analysis in BN gel. A. BN analysis of the heart mitochondria solubilised 
with different concentrations of digitonine. ATPase and the DAPIT protein were detected by antibodies. 
B. The same analysis using the DAPIT KO mitochondria.  
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mtDNA, so the mitochondrial proteins coded by it are absent. Specifically, they lack 
subunits ATP6 and ATP8. The ATPase structure was altered in Rho0 cells given the 
absence of these subunits, and the size of the complex reduced. More importantly, the 
ATPase dimers were not found. Surprisingly, DAPIT was not detected in the ATPase of 
Rho0 cells (Fig. 29). Since Dapit is coded by the nuclear genome, this result indicates that 
DAPIT is bound to the rest of ATPase by the proteins coded by the mitochondrial genome. 
Moreover, the absence of DAPIT may be one of the reasons why the Rho0 ATPase 
complex is unable to form dimers. 
 
 
 
 
Figure  29. The Rho0 mitochondria analysis by BN gel. A-C. In Rho0 cells, the CoI subunit is not 
present in this cell because it is codified by mtDNA. DAPIT is not detected, nor associated with the 
ATPase complex. D-F. In the Rho0 cells without the DAPIT protein, ATPase complex organisation 
differs and several subcomplexes appear. 
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In order to analyse how the absence of DAPIT affected the rest of the ATPase complex, 
ATPase was immunoprecipitated from the tissue mitochondria. After resolving its subunits 
in gradient gel and staining proteins with silver, no differences were detected in the other 
ATPase subunits (Fig. 31). Only a small difference was detected at the bottom of the gel, 
which could correspond to the DAPIT peptide that was absent in the KO ATPase complex.  
 
Taken together, these results indicate that while other subunits are necessary for DAPIT 
assembly in ATPase, DAPIT does not affect the assembly of these subunits. 
 
 
 
 
 
The results reported here indicated that ATPase was the only mitochondrial complex 
affected by the absence of DAPIT. The functionality of this complex was tested in the 
mitochondria isolated from heart and liver. ATP production was evaluated by adding 
different substrates, including glutamate/malate and succinate, to promote the electron 
transfer from complex I or II, respectively (Fig. 31). No differences in ATP synthesis were 
observed between the WT and DAPIT KO mitochondria. This result indicates that ATPase 
dimer formation is not essential for ATP production by mitochondrial ATPase. 
 
 
Figure  30. Immunoprecipitation of the ATPase complex. A. The proteins that form the ATPase 
complex were isolated and resolved in a gradient acrylamide gel and stained with silver. In the WT and 
KO ATPase, the main proteins were identified and a difference was observed only in the band that 
contained the small-sized proteins due to the absence of DAPIT in the KO mitochondria. B. Zoom of 
the part of the gel where the DAPIT protein is. (* is located, indicating the presence and absence of the 
DAPIT protein).  
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All these results show that eliminating the DAPIT protein is a very specific way of inhibiting 
ATPase dimer formation without it affecting ATP production or other subunits of ATPase.  
 
It has been suggested that ATPase dimers are implicated in mPTP opening (Giorgio et al., 
2013). To test this hypothesis, the aperture process was analysed in the isolated 
mitochondria. Addition of calcium to the medium with the heart mitochondria triggered pore 
aperture by altering mitochondrial morphology. This was detected by a change in the optic 
density of the medium, which can be evaluated by absorbance measurements. Taking into 
account the specificity of the signal, demonstrated by mPTP opening inhibition through 
cyclosporine A, no differences were observed between the WT and DAPIT KO 
mitochondria (Fig. 32). This result indicates that the disappearance of the ATPase dimers 
does not affect mPTP opening, and reveals that the ATPase dimers do not form the 
mitochondrial pore. 
 
Figure  31. ATP synthesis in the tissue mitochondria. Analysis of ATP production in the heart 
mitochondria with glutamate/malate (A) or succinate (B) as a substrate. Analysis of ATP production in 
the liver mitochondria with glutamate/malate (C) or succinate (D) as a substrate. (A-D represents the 
ATP production value and SEM) (A p-value=0.0841, B p-value=0.5651, C p-value=0.1339 and D p-
value=0.2520 all by a two-tailed t-test).  
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I.4 Characterisation of DAPIT knockout mouse adult fibroblasts  
 
Next the phenotype of the immortalised mouse adult fibroblasts obtained from the WT and 
KO mice was analysed. After confirming lack of DAPIT by BN (Fig. 33A), ATP synthesis 
was measured in these cells, and no significant differences were detected (Fig. 33B). After 
treatment with different drugs, which allowed the basal and maxima respiratory capacity to 
be studied, no changes in the OCR were observed among the other parameters (Fig. 33C). 
Moreover, lack of DAPIT, associated with ATPase, did not bring about any change in the 
mitochondrial membrane potential (Fig. 33D). Altogether, these results support that DAPIT 
plays no major energetic role. 
 
 
Figure  32. Representation of absorbance variation with time after mPTP opening. Calcium was 
added to trigger mPTP opening in presence or absence of CsA that acts as opening inhibitor.  
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I.5 Role of DAPIT in mitochondria morphology 
 
As ATPase dimers are located on the edge of cristae, their morphology was analysed in 
our mouse model in which ATPase dimers were absent. The cristae morphology was 
analysed by transmission electron microscopy (TEM) in the WT and KO mouse hearts. 
Slightly thinner mitochondrial cristae were detected in the KO mitochondria than in the WT 
hearts (Fig. 34). 
Figure 33. Characterisation of mouse adult fibroblasts (MAFs). Different measurements were 
taken in one clone of WT MAFs and in another clone of KO MAFs. A. BN of the WT and KO MAFs that 
detected DAPIT, ATPb and VDAC proteins. B. Measuring ATP production in the WT and KO MAFs. 
The ATP production and SEM values are represented (p-value 0.244 by a two-tailed t-test). C. Time 
profile of the OCR of the WT and KO MAFs after oligomycin, FCCP, rotenone and antimycin A 
treatment. D. Detection of the mitochondrial membrane potential in the WT and KO MAFs. The value 
membrane potential and SEM are represented (p-value 0.2687 by a two-tailed t-test).  
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Figure 34. Mitochondria transmission electron microscopy analysis. A and B. Heart mitochondria 
images from the WT and KO mice, respectively, at the 5000x magnification. C and D. Heart mitochondria 
images from the WT and KO mice, respectively at the 40000x zoom. E and F. Heart mitochondria images 
from the WT and KO mice, respectively, at the 80000x zoom. G and H. Heart mitochondria images from the 
WT and KO mice, respectively, at the 80000x zoom. I. Representation of how cristae width was measured. A 
mean of four measurements (w1, w2, w3 and w4) was taken to refer to the width of each crista. J. 
Quantification of cristae width in the WT and KO mitochondria (* p-value = 0.0192 by a two-tailed t-test, each 
dot represents one crista; two animals per group were analysed) (bars A-B 2 µm, C-D 0.5 µm and E-H 0.2 
µm).  
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I.6 Characterisation of the DAPIT knockout mice phenotype 
 
The WT and DAPIT KO mice looked similar when grown under standard conditions, and 
were fed chow diet (Fig. 35A-B). To test if some differences appeared under extreme 
conditions, animals were placed on a high-fat diet (HFD). However this diet, which 
contained a higher percentage of fat (60 kcal/g) did not show any difference (Fig. 35C).  
 
 
 
 
 
 
 
 
DAPIT was initially identified as an upregulated protein in diabetes mellitus (Kontro et al., 
2012). To test its role in glucose metabolism, a glucose tolerance test was performed in the 
12-week-old mice. Blood glucose levels were measured before and after glucose 
intraperitoneal administration (Fig. 36A), and a non-statistically significant tendency was 
observed for higher glucose levels in the KO vs. the WT group, although a tendency was 
found in all the seven experiments run (Fig. 36B).  
 
 
 
To ensure that glucose regulation was not affected at any age range, the same experiment 
was repeated by comparing the 12- and the 25-week-old mice (Fig. 37). Once again, 
glucose levels were slightly higher in the KO than in the WT mice in both the 12- and 25-
week-old mice. An age effect on glucose levels was detected as the glucose in the younger 
mice’s blood was rapidly cleared.  
 
Figure 35. Weight of mice. A. Weight of the 12-week-old mice on the chow diet (p-value = 0.5805 by 
a two-tailed t-test). B. Weight of the 24-week-old mice on the chow diet (p-value = 0.5917 by a two-
tailed t-test). A and B, each dot represents the weight of one mouse. C. Weight evolution of the high-fat 
diet. The weight of each group of animals was represented weekly (n=4).  
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Figure 36. Glucose tolerance test. A. Blood glucose levels were measured in the WT (black line) and 
KO (green line) mice in 15- or 30-min intervals after glucose administration (n=5 mice, p-value = 
0.2056 for the area under the curve (AUC) by a two-tailed t-test). A representative plot of the seven 
experiments is shown. B. The mean of several AUCs from seven different experiments (p-value = 
0.1493 by a two-tailed t-test).  
Figure 37. Glucose tolerance test in mice of different ages. Blood glucose levels were measured in 
the WT (black line) and KO (green line) mice, aged 12- and 25-weeks old in 15- or 30-min intervals 
after glucose administration (p-value = 0.5130 for the area under the curve when comparing the 12-
week-old WT and the 12-week-old KO mice by a two-tailed t-test; p-value = 0.1658 for the area under 
the curve when comparing the 25-week-old WT and the 25-week-old mice KO by a two-tailed t-test; 
n=5). 
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Next glucose clearance in response to insulin was analysed, but no differences between 
the WT and KO conditions were observed (Fig. 38). 
 
Taken together, these results indicate that DAPIT does not play a major role in diabetes 
and glucose metabolism. 
 
 
 
 
 
 
 
DAPIT is expressed at very high levels in the heart. To evaluate whether DAPIT affects 
organ function, an echocardiography was done on both the WT and KO mice (Fig. 39). 
Diverse parameters were evaluated, such as blood velocity in the mitral valve, and the E/A 
ratio, which represent the ratio between the top velocity flow in the early diastole and in the 
late diastole, to evaluate the function of the heart’s left ventricle. Ventricle capacity was 
measured as the left ventricle volume in the diastole, the left ventricle mass or heart rate. 
Finally, the ejection fraction (EF) and fractional shortening (FS) values were calculated. No 
differences were observed in these parameters between the WT and DAPIT KO hearts.  
  
 
 
 
 
Figure 38. Insulin tolerance test. Blood glucose levels were measured in the 12-week-old WT (black 
line) and KO (green line) mice in 15-min intervals after insulin administration (n=4 mice, p-value = 
0.2056 for the area under the curve by a two-tailed t-test). A representative plot of the three 
experiments is shown.  
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Figure 39. Echocardiography values representation. The echocardiography values of the WT and 
KO mice are represented. A. Late mitral valve velocity (p-value = 0.6050 by a two-tailed t-test). B. 
Early mitral valve velocity (p-value = 0.9375 by a two-tailed t-test). C. E/A ratio to evaluate the left 
ventricle function (p-value = 0.4377 by a two-tailed t-test). D. Left ventricle volume in the diastole (p-
value = 0.7180 by a two-tailed t-test). E. Left ventricle mass (p-value = 0.6141 by a two-tailed t-test). F. 
Cardiac frequency or heart rate (p-value = 0.8030 by a two-tailed t-test). G. Fractional shortening value 
to measure the fraction of diastolic dimension lost in the systole (p-value = 0.7193 by a two-tailed t-
test). H. Ejection fraction value to evaluate the portion of blood ejected from the ventricle with each 
heartbeat (p-value = 0.5826 by a two-tailed t-test) (n= 6 mice per group, each dot represents a different 
mouse).  
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In the same echocardiographs, it was possible to detect some insufficiencies. They were 
divided into mitral insufficiency (when the mitral valve is unable to perfectly close, blood 
goes backwards from left ventricle), pulmonary insufficiency (the pulmonary valve does not 
work properly and blood goes back from the pulmonary artery to the right ventricle), 
tricuspide insufficiency (the tricuspide valve does not work properly and blood returns from 
the right ventricle to the atrium), and aortic insufficiency (blood goes back from the aorta to 
the left ventricle when the aortic valve does not close properly).  
 
More types and amounts of valvular insufficiencies were detected in the KO mice compared 
to the WT mice (Fig. 40) (χ² = 7.1106, p-value=0.007665).  
 
 
 
 
 
 
By way of example, aortic insufficiency was seen in the DAPIT KO mouse (Fig. 41). In the 
WT mouse (Fig. 41A), blood went from the left ventricle to the aorta, which was showed as 
positive velocity. A different situation was observed in the DAPIT KO mouse (Fig. 41B) as it 
was possible to distinguish negative velocity in the diastole, which indicates retrograde flux 
and aortic insufficiency.  
 
Figure 40. Representation of the number of valve insufficiencies in the WT and DAPIT KO mice. 
Six mice of each genotype were analysed. Green squares represent absence of insufficiency, and red 
ones indicate that one insufficiency type was detected (n.m: it was impossible to measure this 
parameter in this specific mouse). The difference was statistically significant in a chi-square test (χ² = 
7.1106, p-value=0.007665). 
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Figure  41. Representative echocardiography image of aortic insufficiency. A. An analysis of 
blood velocity in a representative WT mouse. B. An equal analysis done in the DAPIT KO mouse (a 
yellow star indicates differences in blood direction and velocity terms).  
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Other insufficiencies as tricuspid (Fig. 42) and pulmonary insufficiency (Fig. 43) were 
observed in DAPIT KO mice. 
 
 
 
 
Figure  42. Representative echocardiography image of tricuspid insufficiency. A. An analysis of 
blood velocity in a representative WT mouse. B. An equal analysis done in the DAPIT KO mouse (a 
yellow star indicates differences in blood direction and velocity terms).  
Figure  43. Representative echocardiography image of pulmonary insufficiency. A. An analysis 
of blood velocity in a representative WT mouse. B. An equal analysis done in the DAPIT KO mouse (a 
yellow star indicates differences in blood direction and velocity terms).  
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To analyse in more detail the heart functionality, a magnetic resonance imaging (MRI) was 
performed in WT and DAPIT KO mice. Different parameters were calculated (Fig. 44) showing a 
weak disffuntion in DAPIT KO hearts, as shown by reduced strock volume (Fig. 44A) and higher 
volume in the ventricles at the end of the systole (fig. 44C-D). All of these parameters together 
indicate a worse heart contraction in DAPIT KO compared with WT mice.  
 
 
 
Figure  44. Parameters calculated by analysis of magnetic resonance imaging. A. Left ventricle 
stroke volume (p-value = 0.0205 by a two-tailed t-test). B. Ejection fraction (p-value = 0.0826 by a two-
tailed t-test). C. Right ventricle ejection fraction (RVEF) (p-value = 0.1869 by a two-tailed t-test). D. Left 
ventricle end-systolic volume (ESV) (p-value = 0.3826 by a two-tailed t-test). E. Right ventricle nd-
systolic volume (RVESV) (p-value = 0.5923 by a two-tailed t-test). F. Right ventricle mass (RVM) (p-
value = 0.3242 by a two-tailed t-test). 
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These results can be visualised representing the volume of both right and left ventricles 
during a pumping cycle. A lower diastolic volume and a higher systolic volume can be 
observed in the KO. This supports the previous data showing impaired contraction of the 
heart in the absence of DAPIT. 
 
 
 
 
 
 
 
 
I.7 Characterisation of mitochondria in MP68 knockout. 
 
The MP68 function was studied primarily in heart and liver tissues. To confirm the absence 
of MP68 in the total KO mice, a mitochondrial protein was analysed under native 
conditions. An analysis of the KO heart mitochondria using a specific antibody confirmed 
that MP68 was lacking in the KO mice (Fig. 46).  
 
Figure  45. Representation of end-systolic volume in right (A) and left (B) ventricle calculated 
used magnetic resonance imaging. The graph star to represent the ventricle volumen after systole.  
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Then the status of mitochondrial complexes I, III and IV was evaluated (Fig. 47), where lack 
of MP68 did not affect the organisation of these complexes. 
 
 
Figure 46. BN to analyse the heart mitochondria. MP68 was not detected in KO heart mitochondria. 
VDAC protein was used as loading control.  
Figure  47. Analysis of the heart mitochondria complexes of the MP68 WT and KO by BN. 
Different complexes of the digitonised mitochondria were analysed. A. The BN of the WT and KO 
mitochondria analysed with a specific complex I antibody that detects the Ndufa9 subunit. B. The BN of 
the WT and KO mitochondria analysed with a specific antibody of complex IV that recognises subunit 
CoI. C. Analysis of complex III by the UQCRC2 antibody. D. Analysis of complex V by the ATPb 
antibody.  
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The heart mitochondria from one WT and two different KO mice were analysed (Fig. 48). It 
can see the band that corresponds to MP68 is present in the WT, but not in the KO mice 
(Fig. 48A). In the same samples, the change observed in complex V is very interesting. 
This complex, detected by ATPb, presents a distinctive organisation in the WT and KO 
mitochondria. Interestly, it was observed that the relation between complex V in the form of 
monomers and dimers is bigger in KO mitochondria thant in the WT ones (Fig. 48B). 
 
 
 
 
 
Interestingly, the monomeric form migrated slightly more in MP68 KO (Fig. 48B) samples, 
as occurs in the DAPIT KO ones.  
 
The liver mitochondria were also analysed (Fig. 49), and the same phenotype was 
observed with both the absence of MP68 in KO and the differential organisation of complex 
V.  
 
Figure 48. Analysis of the heart mitochondria complexes of the MP68 WT and KO by BN. A. The 
BN of the WT and KO mitochondria analysed with a specific MP68 antibody, and VDAC as the loading 
control. B. The previous membrane incubated with specific antibody ATPb that detects complex V. C. 
Merging of previous antibody signals.  
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The different organisation of ATPase was confirmed by using a specific antibody for 
another subunit of ATPase, ATPalpha (Fig. 50).  
 
 
Figure  49. Analysis of the liver mitochondria complexes of the MP68 WT and KO by BN. A. The 
BN of the WT and KO mitochondria analysed with a specific MP68 antibody, and VDAC as the loading 
control. B. The previous membrane incubated with a specific antibody ATPb that detects complex V. C. 
Merging of previous antibody signals.  
Figure  50. Analysis of the heart and liver mitochondria complexes of the MP68 WT and KO by 
BN. A. The BN of the WT and KO mitochondria analysed with a specific MP68 antibody. B. The 
previous membrane incubated with a specific antibody ATPalpha that detects complex V. C. Merging 
of previous antibody signals. 
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Another ATPase subunit, ATP5I, was described as being essential for dimerisation (Arselin 
et al., 2003). This protein was detected in the monomeric and dimer form os ATPase of 
both WT and MP68 KO mitochondria (Fig. 51). 
 
 
In order to see if the amount of used detergent affected the detection of ATPase 
organisation, the digitonin/protein ratio was progressively increased, and was visualised by 
BN gel (Fig. 52). It was possible to confirm the phenotype of the increased amounts of 
ATPase dimers independently on the amount of detergent.  
 
 
Figure  51. Analysis of the heart mitochondria complexes of the MP68 WT and KO by BN. A. The 
BN of the WT and KO mitochondria analysed with a specific ATPb antibody, and VDAC as the loading 
control. B. The previous membrane incubated with a specific antibody ATP5I that detects complex V. 
C. Merging of previous antibody signals. 
Figure  52. Blue Native analysis of the heart mitochondria solubilised at different digitonine 
concentrations. A. MP68 was detected in the liver mitochondria. B. Complex V was detected by the 
ATPb antibody. C. Merging of both signals.  
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All these results together confirm that lack of MP68 affects ATPase organisation by 
promoting its dimerisation.  
 
The relationship between mtDNA codified subunits of ATPase and DAPIT was previously 
described in this thesis. Now, the link between MP68 and these subunits is studied using 
also Rho0 cells. In these cells, the particular pattern of ATPase as well as the absence of 
MP68 in Rho0 cells was observed (Fig. 53). These results indicate that the presence of 
M68 in the ATPase complex depends on the presence of ATP6 and ATP8. 
 
 
 
 
 
DAPIT and MP68 have been described to be of a similar small size, to form the IMD 
domain and to interact with one other. To understand how lack of MP68 could affect the 
interaction of DAPIT with the rest of ATPase, DAPIT was analysed in the MP68 KO hearts. 
While MP68 was not detected in the MP68 KO mitochondria, DAPIT was present in both 
the ATPase monomer and the dimers of the KO and WT mitochondria (Fig. 54). This 
means that MP68 is not necessary to make DAPIT form part of ATPase.  
Figure  53. The Rho0 mitochondria analysis by BN gel. A. In Rho0 cells, ATPase complex 
organisation differs and several subcomplexes appear usin ATPb antibody .B. mtDNA encoded suunit 
detected by using COI antibody. C. MP68 is not detected in Rho0 cells, nor associated with the 
ATPase complex  
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To analyse the opposite, if DAPIT is necessary to correctly place of MP68 in ATPase 
complex, the presence of MP68 was analysed in absence of DAPIT (Fig. 55). In this 
situation no changes were observed, MP68 was located in ATPase complex even in 
absence of DAPIT in both heart a liver mitochondria.    
 
 
 
 
Figure  54. BN to analyse the DAPIT protein in the MP68 KO heart mitochondria. A. MP68 protein 
detection in the MP68 WT and KO heart mitochondria. B. DAPIT detection in MP68 WT and KO heart 
mitochondria. 
Figure  55. BN to analyse MP68 in the DAPIT KO heart mitochondria. A. DAPIT detection in the 
DAPIT WT and KO heart mitochondria. B. MP68 detection in the the DAPIT WT and KO heart 
mitochondria (* autofluorescence).  
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II. DELTARHODOPSIN 
 
 
II.1 Deltarhodopsin expression in mammalian cells 
 
 
To target the HtdR protein in the mitochondria of mammalian cells, the HtdR sequence was 
cloned by adding a mitochondrial target signal (MTS) to the N-terminal domain, based on 
subunit 8 of complex IV, and an HA-tag to the C-terminal domain (Fig. 56A). Stable HtdR 
expression was performed by viral infection in the mammalian control cells, L929mtC57. At 
the total protein level two bands of about 28kDa in weight in HtdR-expressing cells were 
observed (Fig. 56B). The higher band corresponded to the total protein that was 
expressed, and the lower band correspond to HtdR without the MTS. This is the first 
evidence to demonstrate that HtdR is able to enter mitochondria. Next in order to observe 
the importing efficiency to mitochondria, the proportion of HtdR in both the cytoplasm and 
mitochondria was checked. Although the cytosol contained a portion of HtdR (Fig. 56C), the 
largest amount of the HtdR protein was located in mitochondria.  
 
 
 
Figure 56. Deltarhodopsin (HtdR) expression in mammalian cells. A. Scheme of the HtdR 
construct, including MTS-C8 as the mitochondrial target signal (MTS), and HA tag. B. 
Immunodetection with the HA and tubulin antibodies of the total protein from the empty and HtdR-
expressing cells. C. Immunodetection with the HA and Tom20 antibodies of the cytoplasm and 
mitochondria protein from the empty and HtdR-expressing cells. D. Immunodetection of mitochondrial 
proteins of the HtdR-expressing cells after treatment with trypsin with the HA, Tom20 and Tim23 
antibodies.  
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To be functional, HtdR has to reach the inner mitochondrial membrane and be inserted into 
the right orientation. There the H+ gradient is generated and converted into chemical 
energy by ATP synthase. To test HtdR submitochondrial localisation, a protection assay 
was run. Following trypsin treatment, only IMM proteins Tim23 and HtdR remained 
undigested, while OMM protein Tom20 was digested. (Fig. 56D). This demonstrates that 
HtdR is targeted to the IMM, where it should be located to generate a proton gradient. 
 
Next HtdR location was checked by immunofluorescence (Fig. 57). We observed partial co-
localisation with the CoI mitochondrial protein. This effect was due to the higher expression 
levels of the protein and its accumulation in the ER. 
 
 
 
 
In order to improve mitochondrial expression, new proteins with different MTS were 
synthesised, including those from subunit 8 of cytochrome c oxidase (C8) and subunit 9 of 
ATPase (M9), and with sequence Kir2.1, an ER exporting signal (Fig. 58A). 
 
From the analysis of the total protein from the cells that expressed the different constructs, 
it was concluded that HtdR expression existed in all cases. Comparisong of the size of the 
different constructs, confirmed that the small band corresponded to HtdR after the MTS 
was removed, while the bigger band corresponded to HtdR with the MTS (Fig. 58B). The 
removal of the MTS further supports the notion that most HtdR is targeted to mitochondria. 
The C8-HtdR construct displayed the best performance in terms of expression level and 
efficiency of import judging by the cleavage of the MTS. It was, therefore, chosen for the 
following studies. 
  
Figure 57. Immunofluoresce of the HtdR-expressing cells. Detection of HtdR with the HA antibody 
and mitochondria morphology with the CoI antibody. 
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II.2 Cell growth without functional OXPHOS 
 
 
To test the functionality and efficiency of HtdR, cell growth under conditions that force them 
to rely on mitochondrial ATP production rather than on glycolysis was tested by using 
different carbon sources and inhibitors. 
 
Unlike glucose, galactose does not allow cells to generate sufficient ATP by glycolysis to 
survive. However, it provides enough energy if generated by the ETC. Under these 
conditions, the ETC is the main source of energy (Bayona-Bafaluy, Fernández-Silva and 
Enríquez, 2002). In order to block the ETC, we used antimycin A (Aa), an inhibitor of 
complex III. Thus in galactose with Aa, cells cannot use glycolysis or ETC to produce ATP 
and cells die. 
 
Growth of control and HtdR-expressing cells was evaluated in glucose-enriched medium 
that contained Aa for 5 days either in the dark or light. As expected, both the control (Fig. 
59A) and HtdR-expressing cells (Fig. 59B) grew normally because they generated enough 
energy by glycolysis. Neither HtdR nor the used lighting conditions had any apparent toxic 
effect. 
  
Figure 58. Deltarhodopsin with different mitochondrial target signals. A. Scheme of the HtdR 
construct with different mitochondrial target signals. B. Immunodetection of HtdR with different 
sequences that act as the MTS with the HA antibody. 
Results 
 
 
107
 
 
 
 
 
 
When cells were shifted to galactose, the control cells were unable to survive in the 
presence of Aa either in the dark or light (Fig. 60A). On the contrary, the cells that 
expressed the HtdR protein survived in galactose plus Aa, but only if they were illuminated 
(Fig. 60B). This indicates that under light conditions HtDR generates sufficient p.m.f. to 
allow ATP synthesis by mitochondrial ATPase because, in this way, it rescues cells from 
death (Fig. 59B). The possibility that HtdR itself promotes cell survival by a different 
mechanism was ruled out by the fact that cells died in the absence of light. These results 
demonstrate for the first time that mammalian cells can convert light energy into 
electrochemical energy, which is used later by ATPase to produce ATP that can support 
cell growth.  
 
 
 
Figure 59. Growth curve of the cells in the glucose-enriched medium. A. Growth curve of empty 
vector expressing cells in glucose medium in the presence (black continuous line) and absence of light 
(grey discontinuous line). B. Growth curve of the HtdR cells in glucose medium in the presence (red 
continuous line) and absence of light (red discontinuous line). 
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This cellular tool, in combination with the previously developed cell lines that express genes 
AOX and/or NDL1, will allow us to split the different function of the OXPHOS system into 
mammalian cells and to contribute to physiopathology. 
Figure 60. Growth curve of the cells in the galactose-enriched medium. A. Growth curve of the 
control cells in galactose medium in the presence (black continuous line) and absence of light (grey 
discontinuous line). B. Growth curve of the HtdR cells in galactose medium in the presence (red 
continuous line) and absence of light (red discontinuous line) (in the last point: **** p-value < 0.0001 by 
a two-tailed t-test).  
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I. ASSOCIATED PROTEINS WITH ATP SYNTHASE 
 
 
ATPase conformation is important for determining mitochondrial morphology and cristae 
formation. For the first time, we report that DAPIT is necessary for dimer formation. In the 
absence of the DAPIT protein, the capacity to form dimers disappears. The lack of DAPIT 
does not affect to the lost of other ATPase subunits, indicating that our model is a very 
usefull tool to anlayse specifically how affects the lost of the ATPase dimers to the cell. 
Moreover, DAPIT KO ATPase has the same capacity to produce ATP as the WT 
mitochondria, but without the presence of dimers. This indicates that ATPase function is 
independly of it dimeric conformation.  
 
ATPase dimers have been proposed to form the mPTP (Giorgio et al., 2013). Because the 
lack of DAPIT is a specific way to analyse the ATPase dimeres funtion, we presently report 
that the absence of these dimers does not alter mPTP properties according to 
mitochondrial swelling measurements. The capacity of mPTP opening following calcium 
induction remained even in the mitochondrial DAPIT KO. In the future, these results could 
be verified by more specific experiments, including calcium retention capacity 
measurements to calculate the calcium amount threshold that triggers mPTP opening.  
 
Interestingly, the ATPase monomers migrate differently under native conditions between 
WT and DAPIT KO mitochondria. Migration was higher in KO mitochondria than in WT one, 
indicating a small size or different conformation of ATPase monomer that alters the velocity 
of migration.  
 
Apart from the absence of ATPase dimers in the DAPIT KO mitochondria, a new 
subcomplex was detected. We describe this complex as an association of subunits α, β, and 
γ1 from F1, and subunits c from FO. We defined the identity of this subcomplex based on its 
size, and also by the presence or absence of different subunits tested by Western blot, 
which indicates that the alpha and beta subunits are contained in it, but with no e subunit. 
Interestingly, a similar complex was described in the Rho0 cells. In these cells, without 
mtDNA, ATPase is unable to form dimers, but is found in a monomeric form and also in 
other subcomplexes (Nijtmans et al., 1995). One of them, called V*, has a similar weight as 
the subcomplex detected in the DAPIT KO mitochondria. Proteomic assays would be the 
best way to fully characterise the identity of this complex. Analysing its protein composition 
would be the determinant result to ensure how the subcomplex is generated through lack of 
DAPIT. 
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DAPIT was not detected in the proteomic analysis of ATPase from the Rho0 cells. This 
result was explained as a technical limitation (Wittig et al., 2010). Nonetheless, we did not 
detect DAPIT when using the specific antibody, which could indicate that it is very likely to 
be absent in the ATPase of these cells. Lack of mtDNA that encodes subunits A6L and 
ATP8 plays a role as it affects the association of DAPIT with the rest of the ATPase. 
Interestingly, immunoprecipitation was carried out and demonstrated that the ATPase 
complex from the DAPIT KO mitochondria presented all its subunits, except DAPIT itself. 
This evidence led to affirm that the phenotype of absence of dimers observed in Rho0 cells 
could be caused by the absence of DAPIT. This reveals that DAPIT could be one of the last 
proteins to link to the ATPase complex, and that its association to ATPase depends on the 
presence of other subunits. This perfectly matches the fact that DAPIT is absolutely 
necessary for ATPase dimer formation.  
 
 
The following model was proposed by considering all these results together (Fig. 61). In the 
presence of the DAPIT protein, ATPase is found in dimer association (Fig. 61A). However, 
this link is not possible when DAPIT is absent, and ATPase is found in a monomer form 
(Fig. 61B) and in addition, the monomeric ATPase is disestablished and generates a 
subcomplex (Fig. 61C).  
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Recently, a new domain in ATPase has been described, the intermembrane space domain 
(IMD). The IMD may, or may not, be associated with the rest of ATPase, which determines 
two compositional states for IMD (Fischer et al., 2017). These two states do not affect the 
43º curvature of the IMM determined by ATPase. It has been suggested that the IMD is 
formed only by DAPIT and MP68. This indicates that DAPIT and MP68 could be essential 
for determining the ATPase state by acting either together or individually. Furthermore, the 
absence of these proteins would not affect the inner mitochondrial morphology.   
 
Our results in an in vivo model were surprising if we consider previously published results 
in cells (Ohsakaya et al., 2011; Kontro et al., 2015). It has been reported that low DAPIT 
levels in cells affects the amount of ATPase in mitochondria. However, this was not the 
case in the DAPIT KO mice.  
Figure 61. Schematic model showing the consequences of lack of the DAPIT protein. A. ATPase 
dimers are formed in the presence of DAPIT. B. ATPase, in a monomer form, results from lack of 
DAPIT. C. The ATPase subcomplex forms in the absence of DAPIT that contains alpha and beta 
subunits, but not subunit e.  
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DAPIT signifies “diabetes-associated protein in insulin-sensitive tissues” and a role in 
glucose metabolism has been proposed. The generation of the DAPIT KO mouse colony 
was valuable to study the role of the DAPIT protein in diabetes, as previously described. 
DAPIT KO mice were submitted to a glucose tolerance test experiment, in which they did 
not show any defect in terms of clearing glucose from blood. Moreover, they responded in 
the same way as the WT mice responded to insulin administration. Taken together, these 
results suggest that lack of DAPIT does not affect glucose metabolism in the studied 
contexts. It would be interesting to induce diabetes in DAPIT KO mice, follow its evolution 
and determine through experimentation whether the DAPIT protein is required for 
adaptation in these circumstances. 
 
In this thesis, several deficiencies in the cardiac function of DAPIT KO mice were found. A 
blood return was observed in the valves: pulmonary, aortic, tricuspide or mitral, with more 
frequency in DAPIT KO than in WT mice. Moreover, MRI revealed a ventricle stroke 
volume increased in the DAPIT KO hearts that generates impaired contraction of the heart 
in the DAPIT KO mice. Lack of the DAPIT protein somehow affects heart functionality, but 
how DAPIT affects this function is still unknown. In line with this, recently, it was published 
that the lack of DAPIT in zebrafish was associated with the development of dilated 
cardiomyopathy since the fishes with reduced DAPIT levels develop larger pericardial sac 
and atrial areas and reduced ventricular fractional shortening than the WT fishes (Nagata 
et al., 2017). The relationship between DAPIT and cardiac defects was also suggested by a 
mouse model of congenital myopathy. This cardiomyopathy was caused by the lack of 
Klhl31, a skeletal muscle specific gene, and it was found that Dapit gene is one the most 
upregulated genes (Papizan et al., 2017). Similarly, but in skeletal muscle, DAPIT was 
observed as the protein that increased most its levels in a pig model of Duchenne muscular 
dystrophy (Fröhlich et al., 2016).  
 
The DAPIT KO mice are perfectly viable and fertile. These mice are able to live without 
ATPase dimers, which indicates that ATPase complex organisation is not essential for life. 
However, it could be relevant in other contexts not explored herein, such as exercise 
conditions or ageing. Moreover, the DAPIT protein is conserved in metazoan during 
evolution, which well indicates its relevant role. These suggest that other DAPIT functions 
remain hidden whose exploration is pending.  
 
Considering the other subunit that forms the IMD, MP68, a mouse model to study the 
function of this protein was developed. Using this model, a key role in dimer formation 
regulation was demonstrated. The absence of MP68 promotes the dimerisation of ATPase 
in both the heart and liver mitochondria.  
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Moreover, the migration pattern of ATPase under native conditions was also different when 
comparing the MP68 WT and KO mitochondria. This fact could be explained by not only 
lack of MP68, but also by the change in ATPase complex morphology that occurred when 
MP68 was not present in ATPase.  
 
As both proteins form the IMD, and given the faster migration pattern of monomeric 
ATPase in both mouse models, our results suggest that changes in IMD composition could 
alter ATPase conformation.  
 
The lack of MP68 does not affect to the localisation of DAPIT in the ATPase complex. 
Interestingly the opposite was also true; in DAPIT KO mitochondria, MP68 remains in 
ATPase complex when DAPIT is absent. This fact indicates that our mouse models are 
very specific and this allows to study the lack of only one of these proteins.  
 
Although both proteins form part of the IMD, the absence of each one leads to an opposite 
phenotype regarding ATPase dimerisation (Fig. 62). A structural analysis in both mutants 
could clarify how the absence of these proteins affects the ATPase structure and its 
dimerisation.     
 
 
 
 
 
 
 
 
 
 
 
Figure  62. Schematic representation of the role of DAPIT and MP68 in ATP synthase 
dimerisation.  
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II. DELTARHODOPSINE 
 
 
In this work, we demonstrated that light can be used by mammalian cells to obtain energy. 
This was achieved by the expression of the H+ proton-pumping protein HtdR in the IMM. 
This protein uses the energy of photons to translocate protons to the intermembrane 
space, which is used by ATPase to produce ATP from ADP in the absence of functional 
glycolysis and the ETC (Fig. 63). This is a proof of concept that mammalian cells can use 
light as a source of energy.  
 
 
 
 
 
 
This is also a very interesting tool to characterise ETC deficiencies. There are some 
mitochondrial mutations in which it is unclear whether the phenotype is caused by lack of 
energy or by other secondary mutation effects (Kirches, 2011). This tool could be used in 
the future to determine the mechanisms of these diseases. 
 
The use of cell-based robots that can be controlled by the use of light has been recently 
reported (Park et al., 2016). However, this device needs glucose media as a source of 
energy. The possibility of combining this robot with HtdR herein reported could increase the 
independency of these devices by enabling them to obtain their own energy. 
 
There is increasing evidence that metabolism is not only the way cells obtain energy, but 
can also play a role in cell specification and cellular differentiation (Chung et al., 2007, 
2010; Tormos et al., 2011). Using this tool to manipulate the energy status of the cell can 
provide new insights into the role of metabolism. 
Figure 63. Working model that describes the effect of HtdR expression on mammalian cells 
under electron transport chain (ETC) dysfunction. ETC inhibition, due to an antimycin effect, is 
unable to pump protein to the mitochondrial IS. The HtdR is able to restore the proton gradient, which 
can be used by ATP synthase to produce ATP. 
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In conclusion, this work represents the proof of concept that mammalian cells can use light 
energy to grow, and a powerful tool to manipulate metabolism.  
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1. Absence of DAPIT does not affect the viability of mice  
 
2. DAPIT determines dimerisation of the ATPase complex and lack of DAPIT does not 
allow the formation of ATPase dimers  
 
3. Absence of DAPIT generates an ATPase subcomplex that probably contains the 
subunits α, β, and γ1 from F1, and the c subunits from FO 
 
4. The ATPase complex phenotype observed in Rho0 cells could be caused by lack of 
the DAPIT protein in these cells  
 
5. DAPIT deficit does not affect mPTP opening 
 
6. ATPase dimers are not the mPTP 
 
7. DAPIT deficiency in mice does not affect glucose metabolism 
 
8. Lack of MP68 promotes ATPase dimer formation 
 
9. HtdR-expressing cells can use light energy to grow  
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1. La ausencia de DAPIT asociado a la ATPasa no afecta a la viabilidad del ratón.  
 
2. DAPIT determina la dimerización del complejo ATPasa y su ausencia no permite la 
formación de dímeros de ATPasa.  
 
3. La ausencia de DAPIT genera subcomplejos de ATPasa formados probablemente 
por las subunidades α, β, y γ1 del dominio F1, y las subunidades c del dominio FO. 
 
4. El fenotipo de organización del complejo ATPasa observado en células Rho0 puede 
deberse a la ausencia de DAPIT en dichas células.  
 
5. La falta de DAPIT en la célula no afecta a la apertura del mPTP 
 
6. Los dímeros de ATPasa no forman el mPTP.  
 
7. La ausencia de DAPIT en ratones no afecta al metabolismo de la glucosa.  
 
8. La ausencia de MP68 promueve la formación de dímeros de ATPasa.  
 
9. Las células que expresan HtdR son capaces de usar la luz para crecer.  
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